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Executive Summary
1
Healthy People 2010 has two overarching goals: to
increase the span of healthy life and to eliminate
health disparities across the categories of gender,
race or ethnicity, education or income, disability,
geographic location, and sexual orientation (1).
This report raises some conceptual issues and
reviews different methodological approaches
germane to measuring progress toward the goal of
eliminating cancer-related health disparities (2).
Despite the increased attention to social
disparities in health, no clear framework exists to
define and measure health disparities. This may
create confusion in communicating the extent of
cancer-related health disparities and hinder the
ability of public health organizations to monitor
progress toward the Healthy People 2010 cancer
objectives. The recommendations in this report
are based on the following considerations: 
• Choosing a particular measure of health
disparity reflects, implicitly or explicitly, different
perspectives about what quantities or
characteristics of health disparity are thought to
be important to capture. For instance, most
research in health disparities is based on relative
comparisons (e.g., a ratio of rates), but it is equally
appropriate to make absolute comparisons (e.g.,
the arithmetic difference between rates). Figure S1
shows male/female disparities in stomach cancer
mortality during the 20th century. If we use an
absolute comparison (arithmetic difference in
rates), disparities have declined since about 1950;
if we use a relative comparison (ratio of rates),
they have increased almost continuously. This is
an example of how the same underlying data
potentially could generate two divergent
interpretations of trends in cancer-related health
Figure S1. Absolute and Relative Gender Disparity in Stomach Cancer Mortality, 1930–2000 
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Figure S1.  Absolute and Relative Gender Disparity in Stomach Cancer Mortality, 1930-2000
outcomes—dependent on which measure of
disparity is used.
• In this report, we adopt a “population health”
perspective on health disparities. A population
health perspective reflects a primary concern for
the total population health burden of disparities
by considering the number of cases of the cancer-
related health outcome (e.g., mortality, incidence,
screening, etc.) that would be reduced or
eliminated by an intervention. This perspective
emphasizes absolute differences between groups
and the size of the population subgroups
involved. We believe that such an approach offers
a justifiable basis on which to assess the total
population burden of disparity and thus provides
useful epidemiological input into decision making
about policy to reduce cancer-related health
disparities. This in no way precludes that there
may be other valid inputs into the policy-making
process that are based on different perspectives,
such as a purely relative assessment of cancer-
related health disparities. 
• To better monitor the population health
burden of disparities over time, disparity
indicators should be sensitive to two sources of
change: change in the size of the population
subgroups involved and change in the level of
health within each subgroup. For instance, social
policy can change both the number of people
who are poor and the behavior and health status
of the poor. 
Recommendations
We recommend using a sequence of steps,
described below, to assess health disparity. The
first step is to inform any assessment of health
disparity with a simple tabular and graphical
examination of the underlying “raw” data (rate,
proportion, etc., and subgroup population size).
This may provide valuable insights into the basic
question of whether the particular disparity has
increased or decreased over time. The graphical
presentation of the underlying data is depicted in
Figure S2 (page 3), which shows educational
disparity trends in the proportion of women not
having had a mammogram for the past 2 years.
If, as for Healthy People 2010, the goal is to
quantitatively monitor progress toward the
elimination of health disparities across all social
groups, then summary measures of health
disparity are warranted. Figure S2 also contains
two summary measures of health disparity—an
absolute measure, the Absolute Concentration
Index (ACI), and a relative measure, the Relative
Concentration Index (RCI). The choice of specific
summary measures also will be guided by whether
the groups have an inherent ranking (such as
education) or are unordered (such as gender). 
Choosing measures of health disparity
involves consideration of conceptual, ethical, and
methodological issues. This report discusses some
of these issues and provides recommendations for
a suite of measures that can be used to monitor
health disparities in cancer-related health
outcomes.
Our recommendations for measuring
disparity are:
1. To visually inspect tables and graphs of the
underlying “raw” data.
2
2. When the question involves only comparisons
of specific groups, then pairwise absolute and
relative comparisons may be sufficient. When the
objective is to provide a summary across all
groups, then the use of summary measures of
health disparity is warranted.
3. If the social group has a natural ordering, as
with education and income, then we recommend
using either the Slope Index of Inequality (SII) or
the Absolute Concentration Index (ACI) as a
measure of absolute health disparity, and either
the Relative Index of Inequality (RII) or the
Relative Concentration Index (RCI) as a measure
of relative disparity.
4. When comparisons across multiple groups that
have no natural ordering (e.g., race/ethnicity) are
needed, we recommend the Between-Group
Variance (BGV) as a summary of absolute
disparity, and the general entropy class of
measures, more specifically the Theil index and
the Mean Log Deviation, as measures of relative
disparity.
3
Figure S2. Proportion of Women Age 40 and Over Who Did Not Receive a Mammogram in the Past
2 Years by Level of Educational Achievement, 1990–2002, Trends in Absolute and Relative Disparity
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Figure S2.  Proportion of Women Age 40 and Over Who Did Not Receive a Mammogram in the
                   Past 2 Years by Level of Educational Achievement, 1990-2002, Trends in Relative Disparity
Source: CDC, Behavioral Risk Factor Surveillance Surveys 1990–2002. 
*Note: Question not asked in 2001.
Source: CDC, Behavioral Risk Factor Surveillance Surveys 1990–2002.
*Note: Question not asked in 2001.
5Introduction
The goals of this report are to:
1. Highlight major issues that may affect the
choice of disparity measure.
2. Systematically review measures of health
disparity.
3. Provide a basis for selecting a “suite of
indicators” to measure disparities in screening,
risk factors, and other cancer-related health
objectives.
Initiatives to Eliminate Health
Disparities
In 1979, U.S. Surgeon General Julius B. Richmond
first conceptualized the idea for national public
health goals (3) and established specific public
health objectives for reducing mortality and
chronic illness in five age groups, which later were
to be implemented in 15 strategic areas during the
1980s (4). Building on this foundation, Healthy
People 2000 subsequently replaced the age-specific
goals of 1990 with three overarching goals for the
year 2000: increase the span of healthy life,
reduce health disparities, and provide access to
preventive health services (5). The explicit focus
on reducing health disparities in Healthy People
2000 represented an important step toward
establishing health disparities as a part of routine
public health surveillance. Establishing different
health targets for different social groups, however,
could be construed as implying that a group’s
health potential was somehow constrained by its
social-group membership, a factor over which
group members may have little or no control. For
example, the year 2000 target rate (per 100,000)
for cancer mortality was 130 for the total
population, but it was 175 for blacks. 
The implication of setting different targets
for different social groups was not lost on public
health policy makers or politicians. In a 1998
radio address that celebrated Black History
Month, President Clinton put forth a somewhat
more radical national public health goal: “By the
year 2010, we must eliminate racial and ethnic
disparities in infant mortality, diabetes, cancer
screening and management, heart disease, AIDS,
and immunization.” Racial and ethnic disparities
in these and other areas are extensive and well
documented, and given the context of their
origins in the United States, there is ample reason
to focus attention on their elimination. Similar
health disparities, however, are evident not just
between racial/ethnic groups but also between
other social and demographic groups, a fact that
now is reflected in the goals of Healthy People
2010 that specify eliminating health disparities by
gender, income and education, disability,
geographic location, and sexual orientation in
addition to race and ethnicity (1). Similar health
disparity targets also have been adopted by a
number of state and local health agencies (see
6,7,8). The Healthy People 2010 policy goals thus
represent an important shift toward “elimina-
tion,” and not just “reduction,” of existing health
disparities. 
The goal of eliminating health disparities also
implies that a systematic scientific framework
exists to measure health disparities and to
monitor them over time across multiple social
groups and measures of health status. We argue
that no such clear-cut consensus framework
currently exists in the United States, within either
the research or the policy communities as to how
health disparity should be measured. An
important first step toward the elimination of
health disparities is to carefully consider the
conceptualization of health disparity to better
understand what we mean by the term “health
disparity,” how we operationalize the concept of
“eliminating health disparity,” and how then to
apply appropriate health disparity monitoring
strategies.
Cancer-Related Goals of Healthy People 2010
The specific issues that motivate this project are
related to the Healthy People 2010 framework for
cancer-related goals, of which the overarching
goal is to “reduce the number of new cancer
cases as well as the illness, disability, and death
caused by cancer” (9, page 3-3). The objectives
for specific cancers are to reduce the rates of
melanoma, lung, breast, cervical, colorectal,
oropharyngeal, and prostate cancers, and, in
keeping with the goals of Healthy People 2010,
disparities in the above cancers and their major
risk factors also should be eliminated. Thus, this
report focuses on social-group and geographical
disparity in cancer-related outcomes such as risk
behaviors, screening, incidence, survival, and
mortality.
Figure 1 (page 7) is typical of the sort of
cancer-related data that motivate this project.
These data show socioeconomic and racial/ethnic
disparities in lung cancer mortality among U.S.
females for 1995–1999. Although these data help
to characterize disparity, they do not explicitly
quantify the extent or variability in disparity.
Several questions may be asked about this data.
For instance, is the socioeconomic disparity in
lung cancer mortality larger among Asian/Pacific
Islanders or blacks? Or is the racial/ethnic
disparity between non-Hispanic whites and blacks
larger than the socioeconomic differences within
each group? Additionally, variation exists in the
direction of the socioeconomic disparity in
different racial/ethnic groups. Among Hispanics,
the age-adjusted death rate increases as area
poverty decreases; among American Indian/Alaska
Natives, however, rates increase as area poverty
increases. Casual visual inspection of such graphs
reveals that there are differences between and
among groups. The challenge is whether we can
move beyond the simple recognition of such
differences (disparities) toward a strategy to
quantify their magnitude in a scientifically
reliable and transparent way that can be
understood by all stakeholders. This will be even
more important when monitoring changes in
disparity over time.
Figure 2 (page 8) shows the annual rate of
lung cancer incidence by race and gender for the
period 1992–1999. How should we summarize the
disparity in trends in lung cancer incidence? We
might focus on comparing pairs of rates over
6
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time—e.g., the gap between white and
Asian/Pacific Islander females or between black
males and black females. As the number of groups
and years of data increase, however, there are
diminishing returns to such a strategy because of
the large number of possible pairwise comparisons
and the inherent difficulty in summarizing them.
For example, from Figure 2 in 1992, one could
calculate the following incidence ratios: black to
white males, 1.55; Asian/Pacific Islander to
American Indian/Alaska Native males, 2.11; black
to white females, 1.03; and Asian/Pacific Islander
to American Indian/Alaska Native females, 1.71.
The same comparisons in 1999 provide respective
ratios of 1.48, 2.29, 1.12, and 3.33. What can we
conclude about the racial disparity in lung cancer
incidence, given that incidence ratios are
decreasing for some comparisons (e.g., black vs.
white males) but increasing for others (e.g.,
Asian/Pacific Islander to American Indian/Alaska
Native males)? There is no clear way to summarize
the changes in these relative pairwise
comparisons. Therefore, in addition to seeing how
a particular social group’s cancer-related health
outcomes change with respect to another group,
we also may be interested in whether we are
making progress toward eliminating disparities
across all racial/ethnic or socioeconomic groups,
which is consistent with the overarching goals of
Healthy People 2010. That is, we may want to
know whether the disparity in lung cancer
incidence across all racial groups is decreasing.
How should we answer that question when there
are a multitude of pairwise and time-related
comparisons that can be made? Pairwise
comparisons have been the mainstay of
epidemiological effect measures and clearly are
central to disparity measurement, but there also is
a place for summary measures of overall disparity.
Brief History of Measuring Disparities
in the United States
Measuring Disparities in Public Health
This section briefly reviews selected historical
studies of social-group disparities in health
outcomes. Generally, the strong reliance in the
past on pairwise relative and, less frequently,
absolute disparity, and the difficulties such a 
8
Figure 2. Lung Cancer Incidence by Gender and Race/Ethnicity, 1992–1999
1992 1993 1994 1995 1996 1997 1998 1999
160
140
120
100
80
60
40
20
0
R
a
te
 
pe
r 
10
0,
00
0
Year of Diagnosis
Black Male
White Male
API* Male
Black Female
White Female
API* Female
AI/AN** Male
AI/AN** Female
Figure 2.  Lung Cancer Incidence by Gender and Race/Ethnicity, 1992-1999
  * API = Asian/Pacific Islander
** AI/AN = American Indian/Alaska Native
Source: Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: 11
Registries, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch.
*API = Asian/Pacific Islander
**AI/AN = American Indian/Alaska Native
Source: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence—Seer 11 Regs
Public-Use, Nov. 2001 Sub for Expa ded Ra s (1992–1999), National Cancer Institute, DCCPS, Surveill  Research Program, Cancer
Statistics Branch. 
strategy may raise for a broader, more population-
focused understanding of health disparities and
their assessment over time, are emphasized. The
task of measuring disparity in public health
outcomes usually has been taken on by
epidemiologists, who tend to rely on relative risk
measures to characterize effect estimates (10). It is
interesting that few references can be found to
measuring health disparity per se in standard
epidemiological texts. In some ways this is not
surprising, but it helps to explain why standard
epidemiologic metrics, such as relative and
absolute risk differences, have been the general
method of choice applied to measuring health
disparity. A brief guide to health disparity
measurement can be found in a recent textbook
on epidemiologic methods in health policy (11),
but this topic is not addressed in more recent
foundational texts in either general epidemiology
(12,13) or social epidemiology (14). This is not to
suggest that more traditional epidemiologic
measures are not applicable to the measurement
and monitoring of health disparities, but that,
before choosing the methods to best capture
social concerns over the extent of health disparity
and before attempting to devise policies to
reduce/eliminate such disparities, one should be
aware that such measures have certain limitations.
These issues will be discussed in more detail later
in this monograph.
Trends in Social Group Health Disparities
Are health disparities increasing in the United
States? Despite consistent interest in social-group
disparities in public health, limited data provide
information on both social-group characteristics
and health at the national and local levels
(15–17). This in turn has resulted in a relatively
small number of studies of health disparity trends
for the United States as a whole. The landmark
study in the social epidemiology of mortality by
Kitagawa and Hauser (18), which involved a
special matching of 1960 death-certificate records
to the 1960 U.S. decennial census, serves as the
benchmark against which most socioeconomic
disparity trends are referenced. In that study,
Kitagawa and Hauser measured disparity in terms
of the standardized mortality ratio (SMR). The SMR
is calculated as the ratio of the number of
observed deaths to the number expected based on
the mortality rates of the United States as a whole.
If, for example, there is no educational disparity
among white males ages 25–64, then the number
of observed deaths in each educational group
should equal the number expected based on the
mortality rate for all white males ages 25–64,
corresponding to an SMR of 1.0. Kitagawa and
Hauser found, however, that the SMR for white
males ages 25–64 with less than 5 years of
education was 1.15 (i.e., 15% more deaths were
observed than were expected) and was 0.70
among those with a college degree (i.e., 30% fewer
deaths were observed than were expected).
Generally, Kitagawa and Hauser found that higher
socioeconomic position—whether measured by
income or education—was associated with lower
mortality and that mortality was higher among
nonwhite and nonmarried individuals.
Interestingly, they also reported that education
and income had independent effects—income
disparities existed within education groups and
educational disparities existed within income
groups. It is important to note that, in terms of
measuring disparity, this important study relied
on pairwise comparisons of specific groups to the
population average and did not use any summary
measure of disparity.
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Health Disparities According to Income
Pappas and colleagues (19) used the National
Mortality Followback Survey (NMFS) from 1986 to
evaluate trends in education and income
disparities since Kitagawa and Hauser’s 1960
study. To use the information from all
socioeconomic groups, Pappas and colleagues
created a summary disparity measure. Similarly to
Kitagawa and Hauser, they calculated an SMR for
each socioeconomic group within gender and
racial categories based on the sex-race-specific
mortality rates for the entire United States. They
then took the absolute value of the difference
between each socioeconomic subgroup’s (e.g.,
those with <12 years of education) SMR and 1.0
and weighted it by the respective proportion of
the population in that socioeconomic subgroup.
Their index was the sum of these weighted
absolute differences across all subgroups; thus, a
value of 0.5 would be interpreted as the weighted
average deviation of the socioeconomic groups’
SMRs from 1.0. Pappas and colleagues found that
mortality disparities had increased since 1960 for
both whites and blacks, with steeper increases for
income as compared with education as the
measure of socioeconomic position. Thus, because
the sum of population-weighted SMR differences
for income increased more than for education,
they concluded that income-related disparities
increased more than educational disparities. Note
that because each group’s SMR was weighted by its
population share, an increase in disparity when
using this index could be observed even in the
absence of changes in subgroup-specific mortality
rates if the subgroups with the largest SMR
differentials increased their share of the
population. 
Duleep (20) used data linking the 1973
Current Population Survey (CPS) to Social Security
longitudinal mortality data up to 1978 and also
measured disparity by SMRs. Unlike Kitagawa and
Hauser, however, she used her entire CPS
sample—rather than the total U.S. population—to
generate the expected number of deaths in each
income group. She also concluded that
socioeconomic disparities had not narrowed
because the ratio of observed-to-expected deaths
for most but not all income groups was further
from 1.0 in 1973–1978 than it was in 1960. For
example, the SMR for individuals earning $10,000
or more (the richest group) decreased from 0.84 in
1960 to 0.71 in 1973–1978. Schalick and
colleagues (21), using the 1967 and 1986 NMFS,
investigated disparity trends in mortality by
income with different measures of disparity, the
slope index and relative index of inequality. These
disparity measures are similar to the index used
by Pappas and colleagues (19) in that they weight
each socioeconomic group by its population
share, but the index is not based on SMRs. Rather,
income groups are ordered from lowest to highest,
and a line is fitted to the data using weighted
linear regression. The slope of this line is the
resulting “slope” index and is interpreted as the
absolute difference in mortality across the entire
range of income. Dividing this slope index by the
actual mortality rate in the population gives the
“relative” index and is the percent difference in
mortality across the entire range of income.
Similarly to Pappas and colleagues (19), Schalick
and colleagues found that relative mortality
disparities increased when measured by the
relative index of inequality, particularly for males;
they also found that absolute disparities decreased
during the same period when measured by the
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slope index of inequality, primarily because the
absolute declines in mortality were greater for the
least well-off groups. 
Finally, using a different measure of disparity,
the Population Attributable Risk percent (PAR%),
Hahn and colleagues reported that the share of
mortality in the United States due to poverty had
increased from 1973 to 1991 (22). The PAR%
essentially is a summary index designed to
estimate the population health impact of
eliminating health-damaging exposures and is a
function of the prevalence of the exposure and its
associated relative risk. In this case the exposure is
poverty, and the interpretation of the index is the
percent by which the population death rate would
decrease if poverty were eliminated. Thus, the
PAR% is a population-focused disparity index in
that it measures the impact on the total
population of eliminating the health disparity
between the poor and the nonpoor. If the poor
represent a small fraction of the population, or if
the health effects of being poor are small, then
the PAR% will show that the elimination of the
exposure—poverty—will have a marginal effect on
population health. Hahn et al. report that, from
1973 to 1991, the PAR% increased from 16.1% to
17.7%, indicating that the population health
benefit of eliminating mortality disparities by
poverty status increased. The increase, however,
was due entirely to an increased PAR% among
men, as the PAR% decreased for both black and
white women. 
Health Disparities According to Education
Feldman and colleagues (23) investigated trends
in educational disparities in mortality among
whites between 1960 and 1971–1984 using the
matched data of Kitagawa and Hauser and the
first National Health and Nutrition Examination
Survey Epidemiologic Followup Study (NHEFS).
They measured disparity using a standard
epidemiological “rate ratio”—the mortality rate in
the least-educated group divided by the mortality
rate in the most-educated group (i.e., a pairwise
comparison of extreme socioeconomic groups).
The researchers concluded that educational
disparities increased, but this effect was primarily
seen among white men. Interestingly, in their
discussion, Feldman and colleagues noted that the
distribution of education changed enormously
over the period of study but concluded that the
magnitude of the increase was “probably not large
enough to have a major impact on trends in
differentials” (23, page 929). The researchers,
however, did not empirically examine this
assumption, which perhaps is why Elo and
Preston revisited this question using the same
data (24) and conducted a similar analysis of
trends in educational disparity in mortality using
multiple measures of disparity (slope index of
inequality, relative index of inequality) that
account specifically for the changing distribution
of education over time. Similar to previous
analyses (19,23), Elo and Preston found that the
educational disparity had increased among white
men. Whereas Feldman and colleagues found no
change or a small disparity increase for white
women, however, Elo and Preston found that
both absolute and relative disparities had
decreased for white women of all ages. These
studies highlight the important issue of whether
measures of health disparity should be sensitive to
changes in the size of the “exposed group”—in
this case, the most disadvantaged in terms of
income or education. The issue of the effect on
health disparities of the movement of individuals
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into and out of different social groups over time
also is important and has been neglected
somewhat in the United States, despite having
received consistent emphasis in the health
disparities literature (25–27).
The above studies indicate that relative
mortality disparities generally appear to have
increased since 1960, but the extent of disparity
differs with different measures of disparity and
socioeconomic position. Because all of the above
analyses use different data sources and different
measures of health disparity, it is difficult to reach
a firm conclusion as to how much the
socioeconomic disparity in overall mortality has
increased or decreased over time. This perhaps is
not surprising given that, even for simple
disparity measures such as the relative comparison
of the lowest and highest social groups, different
national data sources can provide different
estimates of the size of the same health disparity
(28).
Health Disparities According to Race/Ethnicity
Despite the longstanding interest in health
disparities between racial/ethnic groups in the
United States, surprisingly few studies have
analyzed racial/ethnic disparity trends.
Additionally, the major racial/ethnic focus in the
United States has been on disparities between
blacks and whites (or nonwhites and whites),
which makes understanding trends somewhat less
difficult because the inequality between two
groups may be summarized easily with either a
simple difference or ratio measure. The
continuing increase in U.S. racial/ethnic diversity
and the growing need to compare multiple
racial/ethnic groups and to examine individual
populations that usually are grouped together
(i.e., Chinese with Japanese or Mexican Americans
with Puerto Ricans), however, make the use of
pairwise comparisons for summarizing inequality
trends more difficult to understand and
communicate. The inherent difficulty of talking
about trends in health inequality by reference to
several relative risks is one reason for attempting
to summarize inequality with a single index. One
potential summary measure, the Index of
Disparity (IDisp), was introduced formally by
Pearcy and Keppel (30) and was applied to 17
health status indicators during the period
1990–1998 for five racial/ethnic groups: non-
Hispanic whites, non-Hispanic blacks, Hispanics,
American Indian/Alaska Natives, and Asian/Pacific
Islanders (31). The IDisp measures variations in
health across dimensions of a social group (e.g.,
race/ethnicity) relative to some reference point—
in this case, the total population rate. Thus, a
decline in the IDisp indicates that the variation in
health across racial/ethnic groups declined relative
to the total population rate. From 1990 to 1998,
the researchers found that the IDisp decreased for
most mortality measures and infant health
outcomes (i.e., racial/ethnic disparity decreased),
but increased for teenage pregnancy, motor
vehicle deaths, suicide, work-related injury deaths,
and tuberculosis case rates. It is important to note
that, unlike some disparity measures mentioned
previously, the IDisp does not weight social groups
by their population share. That is, the IDisp takes a
perspective on disparity that what matters is the
difference in subgroup rates of health, regardless
of the number of individuals that may be affected.
Thus, it is more focused on strict equality of
health status measures, regardless of social-group
size and the extent to which social-group health
differences may impact population health.
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Socioeconomic Disparity Trends in Cancer
In general, there have been fewer studies of
socioeconomic disparity trends in cancer
incidence and mortality. One of the difficulties in
monitoring disparity trends in cancer with respect
to socioeconomic groups is that the major source
of data on cancer incidence and survival, the
National Cancer Institute’s Surveillance,
Epidemiology, and End Results (SEER) Program,
does not collect socioeconomic data on
individuals (17). A number of studies, such as
those by Singh and colleagues (32) and Krieger
and colleagues (33), however, have used
information on residential location collected on
incident cancer cases to create a measure of
socioeconomic position. This is accomplished by
linking the neighborhood or county in which an
individual cancer case resides to the U.S. census to
get a measure of the socioeconomic status of that
area—for example, the poverty rate. Such “area-
based” measures of socioeconomic position
certainly are an improvement over having no
measure at all, but they also require additional
assumptions that may hinder their utility for
monitoring cancer-related disparities. For
example, the use of area-based measures assumes
that the average socioeconomic status of the area
is representative of the status of the individual,
and that, because the census is conducted only
every 10 years, the socioeconomic status of an
area in, say, 1990 is an accurate representation of
the same area for a cancer case diagnosed in 1997.
Using area-based measures of socioeconomic
position (e.g., census tract poverty rates), Singh
reported a reversal in the socioeconomic gradient
among men in overall cancer mortality from 1950
to 1998 (34). Singh used relative pairwise
comparisons of the highest and lowest
socioeconomic groups and showed that, in 1950,
mortality rates were 49% higher in higher
socioeconomic areas; this disparity decreased over
the next 30 years and, by the late 1980s, cancer
mortality rates were 19% higher in lower
socioeconomic areas. Thus, over the past 50 years,
the pattern of higher cancer mortality among
individuals in higher socioeconomic areas
disappeared and was replaced by a pattern of
higher cancer mortality among individuals of
lower socioeconomic position. A similar pattern of
reversing gradients also was evident for lung
cancer and colorectal cancers (35). With regard to
cancer incidence, from 1975 to 1999, the trend in
socioeconomic disparity for all cancers among
both men and women was inconsistent (32) as
measured by the incidence rate among those
living in areas with >20% of the population in
poverty relative to the rate in areas with <10% in
poverty (i.e., relative pairwise comparison of
extreme groups). This likely is due to differing
disparity trends for specific cancer sites.
Compared to the highest socioeconomic group,
cancer mortality rates were higher among the
lowest socioeconomic group for lung and prostate
cancers among males, and the ratio of the lowest
to the highest socioeconomic area widened from
1975 to 1999. Incidence of melanoma was higher
among males in higher socioeconomic areas in
1975, and this relative difference increased by
1999. Colorectal cancer was more frequent among
males in higher socioeconomic areas in 1975; the
relative difference decreased by 1999. Among
females, women in poorer socioeconomic areas
had higher incidences of lung and cervical cancers
in 1975; the disparity in lung cancer incidence
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remained relatively constant, whereas the
disparity for cervical cancer declined. Women
living in higher socioeconomic areas had a higher
incidence of melanoma, colorectal, and breast
cancers in 1975; by 1999, this disparity narrowed
for colorectal cancer and widened for breast
cancer and melanoma. This analysis highlights
the importance of examining site-specific rather
than overall cancer trends, as the overall cancer
rate is a diverse amalgam of specific types of
cancer that differ in their etiology and, therefore,
their social distribution. 
Few studies have assessed trends in
educational disparities in cancer. Steenland and
colleagues (36) analyzed trends in educational
disparities in cancer mortality using data from the
American Cancer Society’s Cancer Prevention
Study cohorts (CPS-I and CPS-II). They used
ordinary least squares regression to calculate a
regression-based relative effect of education.
Instead of simply comparing the most- and least-
educated groups, this disparity measure uses the
mortality rates for all educational groups and is
interpreted as the increase in cancer mortality for
each 1-year decrease in the number of years of
education. The study found that educational
disparities increased from 1959–1972 to
1982–1996 for lung and colorectal cancers and
decreased for breast cancer. The researchers did
not, however, account for changes in the social
distribution of education during this period and
were forced to conclude that “the educational
categories were not comparable between the two
populations.” (36, page 20). Thus, their
conclusions were less than clear. If the education
categories are not comparable, and this fact is not
accounted for in the disparity measure, then it is
difficult to know how to interpret the reported
disparity trend among these cohorts.
Racial/Ethnic Disparity Trends in Cancer
Although racial/ethnic disparities in cancer have
received significant attention, especially with
regard to treatment (2,37), relatively few studies
have assessed long-term trends in these disparities.
Again, the general lack of detailed historical
racial/ethnic information in cancer-related data
sources often limits analyses of long-term
disparity trends to a pairwise comparison of
whites and blacks or whites and nonwhites.
Within the last decade, focus on and efforts to
promote population health data for major ethnic
groups have increased. Ten-year trends now are
available for some groups. For subgroups within
major racial/ethnic groups, this is complicated
further by the lack of inter-censal estimates of
population size as well as issues of comparability
of reporting for numerator (incidence) and
denominator (population size) data. Other issues
that arise in comparing groups by race/ethnicity
include differences between subpopulations
commonly grouped together, such as differences
in cancer incidence rates between American
Indians and Alaska Natives and between various
American Indian tribes. 
With regard to mortality from all cancers,
whites had higher mortality rates than nonwhites
until the middle of the 20th century, after which
nonwhites have had higher mortality rates. The
gap between whites and nonwhites increased
from the mid-20th century until the early 1990s,
after which it declined (38,39). The primary
reasons for the widening gap between white and
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nonwhite cancer mortality since mid-century
were relatively larger increases in nonwhite
mortality from lung, prostate, colorectal, breast,
and ovarian cancers (39). 
Still fewer studies have attempted to use any
summary measure of health disparity across
several racial/ethnic groups. Keppel and colleagues
used the Index of Disparity to compare lung and
female breast cancer mortality rates in 1990 and
1998 across five racial/ethnic groups: non-
Hispanic whites, non-Hispanic blacks, Hispanics,
American Indian/Alaska Natives, and Asian/Pacific
Islanders (31). Racial/ethnic disparity declined for
both cancers—significantly so for lung cancer. 
Health Inequality and Health Inequity
The language of “eliminating health disparities”
seems simple and straightforward—something
that everyone understands in the same way and
can agree on. When we say we want to eliminate
health disparity, do we really mean we want
everyone to have the same level of health? Is the
goal that all individuals/social groups should have
the same health, regardless of how healthy or sick
they might be? Or do we mean that it is
improving the health of the most disadvantaged
individuals/social groups so that they approach
the health of the more advantaged (i.e., priority to
the worst-off/least healthy)? In regard to reducing
income disparities, we are comfortable as a society
in considering the need to reduce the incomes of
the advantaged via taxation in order to increase
the incomes of the impoverished. In other words,
we are willing to engage in policy discussions
focused on income redistribution from the rich to
the poor. It is not clear that this idea applies to
health disparity. That is to say, in public health we
generally are not willing to accept health declines
in a healthier or more socially advantaged group
to foster improved health in those who are less
healthy or socially disadvantaged. Yet, it is
plausible that, for example, the health of the rich
and the poor both improve, but the rich improve
at a better rate, therefore increasing the relative
disparity between the two groups. This situation
highlights the possible tension that may arise in
designing policies to simultaneously achieve the
two overarching goals of Healthy People 2010—
improving average health and eliminating health
disparities. Such questions only scratch the surface
but underscore the potential implications of a
literal interpretation of the language of the
Healthy People 2010 initiative to “eliminate”
health disparities (1).
The health disparity concept involves both
descriptive and normative elements. The task is to
understand what the elements are and to develop
sensible measures of disparity that capture both of
these dimensions (40,41). In the United States the
use of the term “disparity” implies two core
concepts. First, it suggests that there are health
“differences” between individuals or social groups;
second, it suggests that such differences in some
way are unfair and an affront to our moral
concepts about social justice. Thus, the term
“disparity” often mixes ideas of “inequality” and
“inequity.” The term “inequality” literally means
difference—that two quantities are not the same—
but the term “inequity” implies an ethical
judgment about those differences. Inequality is a
measurable, observable quantity that can be
reasonably and unambiguously judged; inequity
relies on a moral, ethical judgment about justice
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and thus is not unambiguously measurable or
observable. The classification of health differences
as unequal is a relatively easy task compared to
the classification of health differences as
inequitable. Judgements concerning inequity rely
on social, political, and ethical discourse about
what a society believes is unfair (42).
Another crucial dimension to ideas of
inequity and concepts of justice comes from
discussions about disparities in health that are
avoidable and those that are unavoidable (43,44).
Both types contribute to health disparities, but
only potentially avoidable determinants
contribute to inequity (45). Thus, “avoidability”
implies a capacity to intervene (via social policy,
medical care, etc.) with respect to the
determinants of disparity. It often is difficult to
identify the determinants of disparities or to
distinguish between avoidable and unavoidable
determinants. Determinants of disparity may be
unavoidable in the short run and avoidable in the
long run. It is easier to measure disparity between
groups than it is to identify the determinants of
the disparity or to decide which determinants are
avoidable and which are unavoidable. To
eliminate disparities in health between groups,
however, the determinants of disparities in health
must be identified and avoidable determinants
modified. The first task, though, is to arrive at
methods to identify and quantify health
disparities over time as the basis for evaluation
and action.
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Defining Health Disparities
This section introduces concepts of health
disparity and discusses important issues involved
in their measurement. It also highlights the fact
that “disparity” is a fundamentally ambiguous
concept with multiple dimensions that different
measures of disparity emphasize to a greater or
lesser extent. On its face, the concept of a health
disparity seems rather simple. In fact, when one
attempts to formally define what constitutes a
health disparity, difficulties emerge. For example,
consider the following definitions of what
constitutes a health disparity for the purposes of
measurement: 
“Health disparities occur when one group of
people has a higher incidence or mortality
rate than another, or when survival rates are
less for one group than another.”—NCI
Center to Reduce Cancer Health Disparities,
2003 (46) 
“A population is a health disparity popula-
tion if . . . there is a significant disparity in the
overall rate of disease incidence, prevalence,
morbidity, mortality, or survival rates in the
population as compared to the health status
of the general population.”—Minority Health
and Health Disparities Research and
Education Act of 2000 (47, page 2498) 
“For all the medical breakthroughs we have
seen in the past century, there remain
significant disparities in the medical
conditions of racial groups in this country. . . .
[W]hat we have done through this initiative
is to make a commitment—really, for the first
time in the history of our government—to
eliminate, not just reduce, some of the health
disparities between majority and minority
populations.”—Dr. David Satcher, Former
U.S. Surgeon General, 1999 (48, page 18–19)
“Health disparities are differences in the
incidence, prevalence, mortality, and burden
of diseases and other adverse health
conditions that exist among specific
population groups in the United States.”
—NIH Strategic Research Plan and Budget to
Reduce and Ultimately Eliminate Health
Disparities, Vol. 1, Fiscal Years 2002–2006
Although these definitions share the same
basic sentiment, there are some potentially
important differences that reflect underlying
assumptions (explicit or implicit) about what
constitutes a health disparity. For instance, under
the first definition above, a disparity is a
difference in health between any two populations,
whereas in the second definition (from the law
that established the NIH initiative), a disparity is a
difference in health between some specific
population and the general population. This
definition also introduces the idea that a disparity
must be “significant” in magnitude. These
differences may seem to be inconsequential
semantics, but for the purposes of monitoring
progress toward eliminating health disparities, the
different definitions imply different metrics for
assessing progress. One could imagine a scenario
in which two minority groups have identical
mortality rates, both of which differ substantially
from that of the general population. A more
extreme (but unlikely) scenario might be a case in
which one minority group’s health is better but
not “significantly” different from that of the
general population, whereas another minority
group’s health is worse but also not “significantly”
different from that of the general population. It is
possible, however, that the difference in health
between the two minority groups is “significant.”
Thus, for the same observed data we might
conclude either that a disparity exists (under the
first definition above) or that a significant
disparity does not exist (under the second
definition above). Also note that the definition
offered by former Surgeon General Satcher states
that disparity exists between the minority and
majority population, which suggests a third
possible reference point—the majority
population—though it is not clear how that
majority is to be defined.
Our purpose is not to focus on semantics but
rather to illustrate the lack of clarity in health
disparity definitions and how this is important in
choosing measures to monitor disparity. It is
unlikely we will agree on a single definition of
disparity. It is more likely that there are several
legitimate, competing perspectives on health
disparity that can be adopted. We want to
emphasize the importance of understanding the
link between ethical perspectives and the choice
of quantitative health disparity measures.
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Issues in Evaluating Measures of Health Disparity
This section discusses several issues—conceptual,
pragmatic, and technical—that potentially are
important in choosing health disparity measures.
Many of these issues receive expanded discussions
in the more technical descriptions of the measures
that follow in later sections. The intention here is
to highlight the set of main issues that might be
considered.
Total Disparity vs. Social-Group
Disparity 
There is an important conceptual issue regarding
the specific quantity to be determined when
evaluating health disparities. The fundamental
distinction to be made is between measuring total
disparity, or total variation, and measuring
disparities between social groups. The former
involves evaluating the univariate distribution of
health among all individuals in a population,
without regard to their group membership; the
latter involves assessing health differences
between individuals from certain a priori chosen
social groups. The World Health Organization
(WHO) initiative to measure health inequality, led
by Chris Murray and colleagues, has advocated
strongly for an approach to the measurement of
health disparity as total health disparity among
individuals that is blind to social groups (49,50).
Initially, this seems at odds with our notions of
why we are evaluating disparity in the first place
(51). That is, the initiative to eliminate health
disparities arose within the United States because
of the persistent presence of social-group health
disparities, not out of concern for a widening
overall distribution of health. Yet, a deeper
understanding of the overall task of determining
variation in population health requires that we
appreciate the concept of total health disparity. It
is likely that the between-group disparity we seek
to measure in regard to initiatives such as those in
the United States may be relatively small
compared to the total disparity that exists
between individuals in a population.
Figure 3 (page 20) shows the average body
mass index (BMI) for five education groups in the
1997 National Health Interview Survey (NHIS). It
is clear that there is a gradient of decreasing BMI
with increasing education when comparing
average BMI among education groups. The plots
of the 10th through the 90th percentiles of BMI,
however, show that there is much greater
variation in BMI within education groups than
between education groups. Thus, basing the
measure of health disparity on between-group
average differences may not capture much of the
total health variation among individuals. This is
not a problematic statement itself but should be
understood—and is why indicators of total health
inequality can be informative. Thus, based on the
group averages and a desire to reduce obesity in
the population, focusing a health intervention on
the “high-risk” social group (those with less than
an 8th-grade education) will in practice target only
a limited proportion of those at high risk, because
high-risk individuals exist in every education
group. 
Measures of total health disparity may mask
substantial social-group disparities, however.
Figure 4 (page 21), adapted from Asada and
Hedemann (52), shows the population
distributions of life expectancy in two
hypothetical societies, A and B. Both populations
have the same average life expectancy, but Society
A has a much narrower overall distribution of life
expectancy; were we to use a measure of total
disparity, we would judge Society A to have the
smaller disparity. Within Society A, however, there
is a substantial gap in life expectancy between
social groups 1 and 2, whereas in Society B,
groups 1 and 2 have nearly identical life
expectancy distributions. If we use a measure of
social-group disparity, we likely would judge
Society A as having the greater disparity because
the distribution of life expectancy between the
groups is unequal. The point of this example is to
show that measures of total disparity and
measures of group disparity may or may not lead
to similar judgments about the extent of disparity
in two populations or at two time periods. Thus
far, the evidence seems to indicate that total
disparity and social-group disparity measure
different aspects of population health. Two cross-
national studies found little correspondence
between measures of total disparity and measures
of socioeconomic disparity for either child (53) or
adult (54) mortality. That is, countries with the
largest amount of overall mortality variation did
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Figure 3. Mean and 10th–90th Percentiles of Body Mass Index by Education, NHIS, 1997
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Figure 3.  Mean and 10th-90th Percentiles of Body Mass Index by Education, NHIS, 1997
not necessarily have larger socioeconomic
mortality variation, and countries with the largest
socioeconomic mortality disparities did not have
the largest overall mortality disparities.
Relative and Absolute Disparities
The most frequent method of communicating
information about social disparities in public
health and epidemiology is in relative terms—
through measures of association such as the
relative risk. In epidemiology, relative risks are the
most common measures of “effect size,” partly
because they have advantageous properties not
shared by absolute risk differences (12,55).
Relative and absolute health differences between
social groups are the primary language of health
disparities, but they provide fundamentally
different types of information. Figure 5 (page 22)
demonstrates this essential point by showing
trends in absolute and relative disparity between
males and females in stomach cancer mortality
over the past 70 years. Clearly, there was
enormous progress in reducing stomach cancer
mortality rates among both males and females
during the 20th century. As the rates for both
groups declined, however, the ratio of male-to-
female mortality (i.e., the relative disparity)
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Average Life Expectancy: Society A = Society B
Total Disparity in Life Expectancy: Society A < Society B
Group Disparity in Life Expectancy: Society A > Society B
steadily increased. If the difference between male
and female mortality (i.e., the absolute disparity)
is used as the measure of disparity, however, we
observe a different trend. The male-female gap
increased from 1930 to about 1950, as female
rates declined faster than male rates, and has
declined steadily since 1950. Thus, Figure 5
illustrates the possibility that one might arrive at
opposite conclusions about what happened to this
health disparity, depending on which measure
was chosen—the absolute or relative disparity. The
reason is that the relative disparity cannot reflect
changes in absolute rates—the disparity is relative
to the rate in the comparison group.
Reference Groups
The language of disparity—defined literally as
“difference”—implies a comparison group. A
major question in choosing disparity measures is
the choice of comparison group. As noted above,
the different definitions of disparity imply
different comparison groups, and thus the answer
one would get about the extent and patterning of
disparity may differ according to which groups are
compared. Figure 6 (page 23) shows the situation
for cervical cancer mortality rates among several
racial/ethnic groups. Hispanic women clearly have
the highest incidence of cervical cancer, but how
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Figure 5. Absolute and Relative Gender Disparity in Stomach Cancer Mortality, 1930–2000
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large is the disparity in cervical cancer incidence?
The answer depends on the choice of the
reference group. If the Hispanic disparity is
measured relative to the general population (i.e.,
the total rate), then the relative disparity is 1.75.
If, however, we follow Dr. Satcher’s recom-
mendation (48) and focus on the disparity from
the majority population—non-Hispanic whites—
the relative disparity is 2.21. Or, if the “best-off”
group—American Indian/Alaska Natives—is
chosen as the reference group, we obtain a relative
disparity of 2.43. 
Average Population Member
One logical reference group might be the
population average, where the disparity measure
reflects the gap between the health of different
social groups and the mean health of the entire
population. The population average is appealing
intuitively as a reference point and, as noted
above, often is also used explicitly in defining
what constitutes a health disparity.
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Figure 6. Relative Risk (RR) of Incident Cervical Cancer Among Hispanics According to Varying Reference
Groups, 1996–2000
Total
20
18
16
14
12
10
8
6
4
2
0
R
a
te
 
pe
r 
10
0,
00
0
Non-Hispanic
White
Black Hispanic AI/AN* API**
12.4
7.6
9.6
16.8
6.9
10.2
Figure 6.  Relative Risk (RR) of Incident Cervical Cancer Among Hispanics 
According to Varying Reference Groups, 1996-2000
* AI/AN = American Indian/Alaska Native
** API = Asian/Pacific Islander
Source: SEER Cancer Statistics Review, 1975-2000
RRHispanic vs. Total
RRHispanic vs. NH White
RRHispanic vs. Am Ind/AN
= 1.75
= 2.21
= 2.43
*AI/AN = American Indian/Alaska Native
**API = Asian/Pacific Islander
Source: SEER Cancer Statistics Review, 1975–2000. 
Best-Off Group/Person/Rate
This perspective suggests that one might measure
disparity as a difference between each social group
compared to the healthiest group (or even the
healthiest person). This is similar to Sen’s concept
of shortfalls (56), in which it is assumed implicitly
that every social group in the society has the
potential to achieve the health of the best-off
group. It should be noted, however, that the best-
off social group may be relatively small in size,
which may lead to substantial variation and
instability and could make assessing trends in
disparities more difficult.
All Those Better Off
It also is possible to measure disparities by
comparison to all those individuals or groups that
are better off than a particular group or person.
This may seem similar to the “best-off group”
reference point, but it differs in a subtle way that
may best be illustrated with an example using
actual cancer data. Figure 7 (page 25) shows
cancer incidence from 1996–2000 by race and
ethnicity for two different cancers, kidney/renal
pelvis and myeloma. In both cases, there is a
substantial difference between the group with the
highest incidence rate, blacks, and the group with
the lowest or “best” rate, Asian/Pacific Islanders.
When we look at the incidence rates of other
groups, however, we see two different situations.
In the case of kidney cancer, Hispanics and whites
have rates more similar to blacks, whereas, in the
case of myeloma, they have rates more similar to
Asian/Pacific Islanders. Relative to all those better
off than blacks, most people might judge the
disparity to be worse in the case of myeloma
compared to kidney cancer; yet, if measured
relative to the “best-off” group perspective, we
would be unable to capture this nuance.
Fixed/Target Rate
The prior three reference groups are inherently
relative as they change over time, which may
make assessments of trends in disparities
inconclusive if using pairwise comparisons. One
advantage of a fixed or target rate is that the
reference level does not change over time unless a
new target is adopted. 
Social Groups and “Natural”
Ordering
The Healthy People 2010 initiative mandates
eliminating health disparities within a number of
different types of social groupings: gender, income
and education, disability, geographic location,
sexual orientation, and race and ethnicity. Such
groupings were chosen because they represent
important normative dimensions of U.S. society,
and it has been shown repeatedly that health
differences exist between these social groups. The
above groups, however, also differ in ways that
may have implications for monitoring health
disparities. The social groups that measure
dimensions of socioeconomic position—education
and income—have an inherent ordering regardless
of the health status of their members. Individuals
with less than a high-school education
unambiguously have less formal education than
do individuals with a college degree. The same
cannot be said for the other groups targeted by
the Healthy People 2010 initiative. There simply is
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no inherent way to rank individuals by their race,
ethnicity, disability status, or sexual orientation.
Certain measures of disparity cannot be used to
measure or monitor disparities between groups
that have no implicit ranking. For example, the
slope index of inequality and the concentration
and achievement indices cannot be used except in
the case of education and income, because there
is no inherent way to rank some social groups
such as racial/ethnic groups or genders (except by
their health level). In the Healthy People 2010
parlance, groups with a “natural” ordering include
education and income but do not include gender,
race/ethnicity, sexual orientation, disability status,
and geography.
The Number of Social Groups
Should the measure of disparity include
information from all social groups (i.e., the entire
population), or is it sufficient to reflect only the
experiences of the best- and worst-off (extreme)
groups? Many empirical studies of health
disparities measure disparity by comparing the
extreme groups (e.g., the lowest income group
compared with the highest income group). This,
however, ignores the health status of other groups
and additionally may only reflect the disparity
between two very small population groups. For
example, in 2000 there was a three-fold relative
difference in death rates from melanoma of the
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Figure 7. Age-Adjusted Incidence of Kidney/Renal Pelvis Cancer and Myeloma by Race and Ethnicity,
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Source: SEER Cancer Statistics Review, 1975–2000.
Source: SEER Cancer Statistics Review, 1975–2000. 
skin across U.S. states. The states with the lowest
(North Dakota, 1.3 per 100,000) and the highest
(Wyoming, 3.7 per 100,000) rates, however,
collectively accounted for only 0.4% of the U.S.
population in that year. Eliminating this disparity
would have little impact on reducing the
population burden of melanoma mortality
because only a fraction of melanoma cases reside
in these two states. Additionally, although there
are good reasons for focusing attention on specific
comparisons, such as the disparity between blacks
and whites in the receipt of treatment for cancers
of similar stage (57), such pairwise comparisons
do not quantify the disparity across all
racial/ethnic groups, which is precisely the goal of
initiatives to eliminate health disparities by the
year 2010. For example, the gap between white
and black men in the recent use of fecal occult
blood test (FOBT) screening for colorectal cancer
narrowed between 1987 and 1998 (58); however,
this pairwise comparison conceals the fact that
the gap between Hispanics and whites and
between Hispanics and blacks increased (see
Figure 8). Despite the utility of measuring
disparities between two groups, pairwise
comparisons may conceal important
heterogeneity and thus provide a limited view in
monitoring progress toward eliminating health
disparities across the entire range of social groups.
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Figure 8. Proportion of Men Reporting Use of Screening Fecal Occult Blood Tests (FOBT), by Race and
Ethnicity, 1987–1998
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Figure 8.  Proportion of Men Reporting Use of Screening Fecal Occult Blood Tests 
                (FOBT), by Race and Ethnicity, 1987-1998
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Population Size
Should the disparity measure incorporate the size
of the groups being compared? If we use a
pairwise comparison of extreme groups, would it
matter that one or both of those groups comprises
a very small proportion of the population? For
example, Pearcy and Keppel’s Index of Disparity
(30) gives equal weight to each group, even
though the groups may represent different
proportions of the population. This has important
implications for monitoring disparities and is
another case in which a statistical choice reflects
an ethical choice. That is, the decision of whether
or not to weight social groups by their population
size also is a decision regarding how much weight
to give individuals within each social group. For
example, if we measure the disparity in prostate
cancer mortality among U.S. states in 2000
without weighting states by their population size,
California and Wyoming receive equal weight
despite the fact that California has nearly 70
times as many males as Wyoming. Thus, in an
unweighted analysis of U.S. states, individual
males in California receive approximately 1/70th
the weight of males in Wyoming. 
Another important issue in using unweighted
measures of health disparity is their inability to
incorporate the demographic changes that
inevitably occur over time. For example, Figure 9
(page 28) shows the percentage increase in
population subgroups between the 1980 and 2000
Census (59). These demographic shifts can have
enormous impact on the population’s health and
should be factored into the assessment of health
disparity. In their analysis of the effects of
education on all-cause and cause-specific
mortality in the American Cancer Society’s Cancer
Prevention Study cohorts (CPS-I and CPS-II),
Steenland and colleagues (who used ordinary least
squares regression) noted that changes in the
distribution of education made it difficult to
compare the extent of disparity between the two
populations studied (36). The proportion of the
population with less than a high-school education
was 20% in CPS-I and 6% in CPS-II, while those
with a college degree were 16% and 30% of the
population in the two respective cohorts. In
epidemiological language, the proportion of the
population “exposed” changed dramatically with
large population shifts out of the most
disadvantaged groups. For a measure of health
disparity to allow for an unambiguous
comparison across time, it should be sensitive to
changes in the distribution of social groups over
time. This sensitivity to changes in the proportion
of people exposed to disadvantageous social
positions especially is important when
considering the so-called “upstream”
determinants of health disparities. It is
commonplace in health disparity research to
discuss how distal social policy affects health and
health disparity. The policies and programs that
define the nature of stratification in a society
create educational opportunity, allocate income,
and affect the types of jobs that are available.
When these “upstream” social policy factors affect
the nature of social stratification by reducing the
number of minimally educated individuals, for
instance, thus reducing the number of individuals
exposed to that form of social disadvantage, then
measures of health disparity should account for
that change. The same situation exists when the
proportion of a particular population subgroup
changes over time, as in the case of the migration
of Hispanics and Asian/Pacific Islanders as shown
in Figure 9.
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Socioeconomic Dimension
Another potential criterion for a measure of
health disparity, first articulated by Wagstaff and
colleagues (60), is whether the measure is able to
capture health gradients associated with
socioeconomic position. By health gradients, we
mean a situation where a measure of health status
either increases or decreases with increasing
socioeconomic position. A good example is the
increasing rate of cancer incidence among
individuals living in U.S. counties with
successively higher poverty rates (32). That is, is
the measure sensitive to the direction of the
association between social group and health? For
instance, if at one time health status increases
with social-group ordering and at another time
health decreases with the same social-group
ordering, the disparity measure will reflect this
change if it is sensitive to the direction of the
gradient. Of necessity, this criterion is applicable
only for measuring inequality between social
groups that have an inherent ranking. The lack of
inherent ordering among racial/ethnic groups, for
example, means that the “socioeconomic
dimension” criterion cannot be applied to
disparity measures used to monitor racial/ethnic
health disparities. 
Figure 9. Percent Change in Population Size by Race and Hispanic Origin, 1980–2000
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Monitoring Over Time
Inherent in the goals of Healthy People 2010 is the
idea that we monitor progress toward the
elimination of health disparities. That means it is
desirable that measures of disparity are
interpretable over time. This represents important
challenges for the use of simple pairwise relative
disparity indicators and indicators that are not
population-weighted. Because both the health
status within different social groups and the
population distribution of social groups change
over time, which together reflects the overall
public health burden of health disparities,
measures that are sensitive to both dimensions of
change may be more suitable for monitoring
disparities over time. 
Transfers
The issue of how measures of disparity respond to
hypothetical transfers between individuals has
been an important part of evaluating the
performance of income disparity measures in
economics. The major test in economics is the
principle of transfers—sometimes called the
Pigou-Dalton condition (61,62)—which maintains
that a transfer of income from a richer to a poorer
person should result in a decrease in the measure
of disparity (assuming that everyone else’s income
remains unchanged and the transfer is not large
enough to reverse anyone’s relative positions).
This is an intuitively powerful and desirable
notion that corresponds well with what we
believe disparity measures should be able to
capture. Yet, theoretically, this is a somewhat
difficult concept to employ for judgments about
health disparity. Is “health” a fungible good like
income that can be redistributed in different
ways? It is hard to imagine social mechanisms
(perhaps apart from organ donation) through
which a “healthy” person can directly transfer
some of her health to someone who is less
healthy, though it is possible to conceive of
redistributing health resources. The task, however,
is to measure disparities in health, not health
resources. 
We have noted that measuring disparity in
health versus income differs in at least one
important respect, namely that goods such as
income or wealth are, in fact, transferable from
one individual to another. One potential way to
avoid this difficulty is to think of comparing
disparity in two different populations (e.g., in two
repeated observations of a cohort). One might
then think of a transfer-like principle according to
which we evaluate a measure of health disparity.
If the health of every individual remains the
same, but a single “healthier” person becomes less
healthy and a previously “less healthy” person’s
health improves, the measure of health disparity
should decrease (25). This seems a plausible-
enough principle to warrant evaluating a measure
of health disparity, but health disparities and
income distributions are dissimilar in another
way. Even if we are willing to put aside the issue
of the literal inability to “transfer” health, it is not
at all clear in the previous example that we would
be willing to accept the decreased health of one
person for the sake of increasing the health of
another. For income, this is not a problem
because it is the distribution of the good itself that
is under question. Most people generally believe
that it is unfair that some have enormous
incomes while others live in extreme poverty. Do
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we truly believe, however, that some individuals
possess more than their fair share of health? As
was emphasized earlier, one of the major reasons
for the increasing focus on health inequalities is
not simply that some are healthy while others are
sick. It is that some kinds of individuals or the
members of some social groups are healthy while
other kinds are sick. It is the normative
distinction between the kinds of healthy or
unhealthy individuals that drives our concern
that health differs so markedly by social group.
The concern over health disparities then, at least
in the current historical period, is not that there
are health differences in society but that these
health differences systematically covary with
membership in particular social groups. 
Subgroup Consistency
Generally, this criterion says that if the measure of
overall disparity includes, for example, three
groups, and disparity within two groups remains
unchanged while increasing within the third, the
measure of disparity should increase. This is of
most relevance when we are interested in
measuring the overall disparity (i.e., across the
entire population). For instance, suppose we were
examining alcohol consumption at two points in
time in a population composed of two social
groups (rich and poor). At each time, both the
size of these groups and their average alcohol
consumption remain constant, but the disparity
in consumption increases within the poor and
remains constant within the rich. Subgroup
consistency requires that any measure of overall
disparity also should register an increase in this
scenario. This is not likely to be an important
criterion for health disparity measures in the
context of Healthy People 2010 because it does not
focus on health disparities within subgroups of a
social group (e.g., within the poor).
Decomposability
Decomposition as a property of statistical
measures is common in both economics and
epidemiology. In economics, it typically refers to
the ability to decompose a measure of disparity by
sources of income or into between-group and
within-group partitions (40). Decomposable
disparity measures are seen as advantageous as
they can offer information about the sources of
increasing or decreasing disparity as indicated in a
summary statistic. In public health,
decomposition often is used to capture differences
in summary rates. For example, a difference in
age-adjusted mortality rates between two
populations can be “decomposed” into differences
between mortality rates and differences in age
structure. 
Scale Independence
Scale independence (or invariance) often is seen
as a desirable property of disparity measures. It
often is argued that, all else being equal, if
everyone’s health “doubles,” the disparity
measure should remain unchanged. It is arguable,
however, whether for public health, where we also
are concerned about the absolute level of ill
health, this is a desirable property. 
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Transparency/Interpretability for
Policy Makers
Finally, it seems salient that an interpretability
criterion be included as a factor in decisions about
measures of disparity. For instance, despite other
desirable properties, the actual value of more
sophisticated summary measures such as the
Concentration Index have no obvious
interpretation and thus may make
communicating health disparity indices to the
community and policy makers potentially more
difficult. Thus, the extent to which different
measures of disparity can be captured graphically
to aid communication might be important in
deciding which measures are most appropriate for
monitoring cancer-related health disparities.
Perhaps the use of real-time graphical displays of
changes in outcomes of interest may aid the
understanding of health disparity. This dimension
of health disparity monitoring should not be
underestimated, as evidenced by the lack of
general application of more sophisticated disparity
measures in health disparity research.
31
33
Measures of Health Disparity
This section reviews most of the statistics that are
available to measure health disparities. The goal is
to provide a brief overview of each measure,
followed by the method of calculation and
statistical interpretation and, often, an example of
its actual or potential use for measuring disparities
in cancer-related health objectives. 
Note that there are methods to calculate
indicators of precision (e.g., 95% confidence
interval) for all of the measures reviewed here.
These can be found in the source publications
detailed in the references. Although issues of
variability and precision are important, they are
not germane to the choice of disparity measure
because they ultimately derive from the precision
of the underlying rates, prevalence, and
proportions that are used to generate a particular
disparity measure.
Measures of Total Disparity
A measure of “total disparity” in health is a
summary index of health differences across a
population of individuals. Generally, measures of
total disparity do not account for social grouping
and have been used chiefly by health economists
(see, for example, 25,49). They are an important
first step in understanding the scope of health
variation in a population and have advantageous
properties for monitoring trends, particularly for
cross-country comparisons. They do not, however,
inform about systematic variation in health
among population subgroups, which is inherent
in the Healthy People 2010 health disparity
initiatives. The measurement of health disparity
as total disparity is associated most closely with
and endorsed by the WHO as a component of its
general framework for routinely assessing the
performance of health systems in different
countries. The WHO, however, is not the only
advocate of measuring total disparity. Some
health economists also advocate for the
measurement of total health disparity (25,63,64)
as the primary form of assessing health
inequalities.
A number of criticisms have been levied at
this kind of measure, primarily because it does not
distinguish among individuals from different
social groups (51,53,54,65). In addition, empirical
investigations using measures of total disparity
appear difficult to interpret (54,66,67). Those who
endorse this measure often cite as their primary
justification the weighty normative choices that
must be made to measure health differences
between social groups and note that the absence
of such a priori choices makes disparity between
individuals a more “objective” measure of health
disparity. We recognize that Healthy People 2010
specifically calls for social-group monitoring and
not total variation, but we include measures of
total group disparity because they are prominent
in the overall framework of efforts to monitor
global health disparity and because they provide
an essential context for understanding the
“decomposition” of health disparity measures, as
described below. 
Individual-Mean Differences
Individual-mean difference (IMD) measures of
health disparity calculate the difference between
the health of every individual in the population
and the population average. The general formula
for the class of individual/mean difference
measures is given by Gakidou and colleagues (49)
as: 
[1]
where an individual i’s health is yi, µ is the mean
health of the population, and n is the number of
individuals in the population. The parameters α
and β specify, respectively, the significance
attached to health differences at the ends of the
distribution relative to the mean and whether the
individual-mean difference is absolute or relative
to the mean health of the population. For
instance, large values of α emphasize greater
deviations from the mean, and larger values of β
emphasize relative disparity because of heavier
weighting of the mean. Those familiar with basic
statistics will note that, when α = 2 and β = 0, the
IMD simply is the variance; and when α = 2 and
β = 1, the IMD is the coefficient of variation (49).
Similar to many other disparity measures, the IMD
is a “dimensionless” index that is not measured in
units because it always is relative to the mean in
the population.
Inter-Individual Differences (IID)
The IID measures health differences between all
individuals in the population and is consistent
with the Gini coefficient but may be weighted in
accordance with differential aversion to disparity
(i.e., the value chosen for α). These measures are
different from the IMD class because they
compare every individual in the population with
every other individual in the population, whereas
the IMD measures disparity relative to the
population average. It should be clear that
different measures of disparity implicitly express
different perspectives on which aspects of
disparity should be emphasized in the measure.
The class of inter-individual difference measures is
(49):
[2]
where yi is individual i’s health, yj is individual j’s
health, µ is the mean health of the population,
and n is the number of individuals in the
population. The parameters α and β are defined as
for the IMD above, and it is worth noting that,
when α = 2 and β = 1, the IID is equal to the more
well-known Gini coefficient. Gakidou and King
have used this disparity measure (with α = 3 and
β = 1) to compare total disparity in child survival
among 50 countries (68). Weighting α = 3 implies
that the measure should be more sensitive to
larger than smaller pairwise deviations between
individuals and thus reflects additional concern
about larger health differences between
individuals. To our knowledge, there is only one
study of total disparity that uses data from the
United States (69).
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Measures of Social-Group Disparity
The measures of total variation described above
have a number of merits, including their ability to
make unambiguous health disparity comparisons
between populations and over time. In defining
health disparity as disparity between individuals
instead of between social groups, such measures
avoid the difficulty of comparability of groups
between populations or over time (50). This
makes them particularly attractive for cross-
country comparisons, in which defining
comparable social groups is challenging because
of differences in how social groups are classified
in different countries (70).
The disparity goals of Healthy People 2010,
however, explicitly are goals that relate to social-
group differences in health. It is an open question
as to whether measures of total disparity and
social-group disparity are “better” or “worse”
disparity measures, but the concern among health
policy makers in the United States specifically is
expressed in terms of social-group differences in
health. Measures of total disparity therefore are
insufficient for monitoring progress toward
eliminating cancer-related health differences
among social groups in the United States.
Pairwise Comparisons
Simple comparisons of some health indicator
between two groups in a population (so-called
pairwise comparisons) clearly are one of the most
straightforward ways to measure progress toward
eliminating disparities between groups. For
example, age-adjusted incidence rates of lung
cancer for black and white females in 1973 were,
respectively, 23.6 and 20.4 per 100,000. By 1999,
rates for both groups had increased, to 57.0 for
blacks and 52.3 for whites (71). It would seem
easy enough to answer the question: Did black-
white disparity grow from 1973 to 1999?
Unfortunately, however, the answer depends on
the measure of disparity. If the disparity measure
is the absolute difference between the black and
white rates, then we would conclude that the
black-white disparity increased from 3.2 to 4.7.
If the disparity measure is the relative difference
between the black and white rates (i.e., black
rate ÷ white rate), however, we would conclude
the opposite because the relative disparity
decreased from 1.16 to 1.09. Both answers are
correct. This has been a source of continuing
confusion and sometimes unresolved debate in
the health disparities literature (72,73) and,
although most of the empirical work in health
disparities has been in terms of “relative
disparity,” it should always be kept in mind that
large relative differences can mask very small
differences in absolute terms, which can be
misleading with respect to the disparity’s
population-health impact. Conversely, there may
be situations where large relative disparities may
be viewed as grossly unjust, despite the fact that
they reflect small absolute differences.
Absolute Disparity
The absolute disparity between two health-status
indicators is the simple arithmetic difference. It is
calculated as:
[3]
where r1 and r2 are indicators of health status in
two social groups. In this case, r2 serves as the
reference population, and the AD is expressed in
AD = r1 – r2
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the same units as r1 and r2. A typical disparity
measure that uses the absolute difference between
two rates for an entire population is the range,
where case r1 above corresponds to the least-
healthy group and r2 to the most-healthy group. 
Relative Disparity
For the same pairwise group comparison in
equation [3], we also can divide r1 into r2 to
calculate the relative disparity as:
[4]
where, again, r2 is the reference population. This
rate ratio can be transformed easily into a
percentage difference by multiplying the ratio by
100. Figure 10 shows the absolute and relative
black-white disparity for prostate and stomach
cancer incidence from 1992–1999. Clearly, there is
a much larger absolute disparity in prostate cancer
incidence because the rates for both groups are
relatively high compared to the stomach cancer
rates; however, the relative disparity is larger for
stomach cancer.
Regression-Based Measures
One drawback of the pairwise comparison
measures of disparity is that, when a social group
has more than two subgroups (as most do),
information on the other groups is ignored.
Normally it is desirable to use as much of the
information present in the data as possible. If we
RD = r1/r2
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Figure 10. Absolute and Relative Black-White Disparities in Prostate and Stomach Cancer Incidence,
1992–1999
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compare the “best” group to the “worst” group,
we effectively ignore the information on the
health status of all the groups in between, aside
from knowing that they fall somewhere between
the best and worst groups. One possible solution
would be to calculate a series of (j–1) pairwise
comparisons for j groups using one group as the
reference point, or j pairwise comparisons using
an external reference point. Although feasible, as
the number of groups, time periods, or both
increases, attempting to evaluate the disparity
trend may become complicated in terms of
summarizing the many pairwise comparisons. To
overcome this limitation and make use of the
information for all groups, one might consider
calculating a summary measure of disparity. This
choice, however, undoubtedly involves additional
complexity and assumptions that must be traded
off against the insights about disparity gleaned
from the use of a summary measure (74).
Simple Linear Regression
If one is willing to assume that the relationship
between social group and health status is linear
(i.e., that each step up the social-group scale
results in an equivalent health gain/loss), then a
potential way to include information on all of the
groups is to calculate a summary measure of
disparity using regression. One way of writing this
is:
[5]
where yi is a measure of health status for
individual i, β0 is the value of the health variable
when Xi is 0 (e.g., if Xi is a continuous measure of
income, then β0 is the health status of an
individual with zero income), Xi indexes social
group, and β1 is the summary measure of
disparity. In general terms, β1 is equal to the
covariation of Xi and yi expressed in terms of the
variance of Xi. The specific interpretation of β1
depends on the particular health status measure
used and the specification of the model. If yi is an
untransformed health status measure—for
example, BMI—then β1 is the absolute increase in
BMI associated with a one-unit change in social
group and is referred to as a Regression-Based
Absolute Effect or RAE (70). It is an absolute
measure because it is expressed in the same units
as the quantity of health measured in yi.
Continuous types of health outcomes, however,
are relatively less common in the area of cancer-
related data. More likely are noncontinuous types
of health data (e.g., the presence or absence of
cancer, receipt or nonreceipt of screening), where
the linear relationship in equation [5] applies to
some transformation of the dependent variable yi.
For transformations of the dependent variable yi
(e.g., the logarithmic or logit transformation),
β1 then becomes a relative-risk (logarithmic
transformation) or odds-ratio (logit
transformation) and is interpreted as the
proportional increase in health status for a one-unit
change in social group and referred to as a
Regression-Based Relative Effect or RRE (70).
Figure 11 (page 38) graphically shows a simple
regression-based disparity measure, applied in this
case by Steenland et al. to the risk of lung cancer
among men of different education groups
(grammar, some high school, high-school
graduate, some college, college graduate) in the
1982–1996 Cancer Prevention Study II (36). The
y-axis is the risk of mortality relative to those
completing graduate school (whose relative risk is
by definition equal to 1.0), the x-axis is the
approximate number of years of education for
each education group (Xi in equation [5]), and the
fitted line indicates the linear decrease in relative
yi = 0 + β 1X i β
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risk—which Steenland and colleagues reported as
about 10%—for each 1-year increase in the
number of years of education. (It is important to
note that, for ease of presentation, the plotted
points in Figure 11 show only the average relative
risk for each education group. The actual
regression equation is performed on all 500,000 or
so individuals in the CPS-II.) Relative-effect
measures also may be transformed into absolute
effect measures by applying them to the rates of
health in the referent social group. An additional
drawback to the RAE and RRE is that the
assumption of linearity between health and social
group may be problematic. For example, while
Kunst and colleagues find linear associations
between education and self-rated health (75),
Manor et al. report nonlinearity between
education and a number of chronic conditions
(76), and Backlund and colleagues report a
nonlinear association between income and
mortality (77).
Slope Index of Inequality
The regression-based methods outlined above,
subject to the assumptions of the model, work
well for calculating a summary measure of health
disparity at a single point in time. As noted above,
however, over time the distribution of the
population in various social groups may change
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Figure 11. Example of a Simple Regression-Based Disparity Measure
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Figure 11.  Example of a Simple Regression-Based Disparity Measure
Source: Adapted from Steenland et al. Am J Epidemiol 2002;156:11-21.Source: Adapted from Steenland et al. Am J Epidemiol 2002;156:11–21. 
drastically, and it would be advantageous for a
measure of health disparity to be sensitive to such
changes. One measure that does so is the Slope
Index of Inequality (SII). To calculate the SII, the
social groups first are ordered from lowest to
highest. The population of each social-group
category covers a range in the cumulative
distribution of the population and is given a score
based on the midpoint of its range in the
cumulative distribution in the population. For
example, in the 2001 NHIS those with an income-
to-poverty ratio of less than 0.5 (approximately
<$9,000 for a family of four) were 3.45% of the
population, and those in the next highest income
group—with an income-to-poverty ratio of 0.5 to
0.74—comprised 3.02%, in which case the lowest
group is assigned a score of [0 + (.0345 – 0)/2] =
.0173, and the next lowest group is assigned a
score of [.0345 + (.0647 – .0345)/2] = .0496. 
Health status then is plotted against this
midpoint socioeconomic category variable, and a
regression line is fitted to the data. The SII thus is
similar to the regression-based methods above,
but differs because it uses the midpoint of the
cumulative social group distribution and because
it (usually) is based on grouped data and is a
weighted index, where the weights are based on
the size of the social groups. By weighting social
groups by their population share, the SII is able to
incorporate changes in the distribution of social
groups over time that affect the population health
burden of health disparities. Figure 12 (page 40)
shows the predicted slope for the income disparity
(based on income-to-poverty ratio) in current
smoking for the United States in 2001. Note that,
in Figure 11, the location of the data points on
the x-axis is based on the estimated number of
years of education, whereas in Figure 12, the
location is based on the group’s share of the
population. This reflects the fact that the
education groups actually comprise different
proportions of the population distribution.
Formally, the SII, which was introduced by
Preston, Haines, and Pamuk (78), may be ob-
tained via regression of the mean health variable
on the mean relative rank variable:
[6]
where j indexes social group, is the average
health status, is the average relative ranking of
social group j, β0 is the estimated health status of a
hypothetical person at the bottom of the social
group hierarchy (i.e., a person whose relative rank
Rj in the social group distribution is zero), and β1
is the difference in average health status between
the hypothetical person at the bottom of the
social group distribution and the hypothetical
person at the top (i.e., Rj = 0 vs. Rj = 1). Because
the relative rank variable is based on the
cumulative proportions of the population (from
0 to 1), a “one-unit” change in relative rank is
equivalent to moving from the bottom to the top
of the social group distribution. Because this
regression is run on grouped data (as opposed to
individual data as in equation [5]), it is estimated
via weighted least squares, with the weights equal
to the population size nj of group j (60). The
coefficient β1 in equation [6] is the SII, which is
interpreted as the absolute difference in health
status between the bottom and top of the social-
group distribution. Thus, the regression equation
in Figure 12 shows that the absolute difference in
the prevalence of smoking across the entire
Rj 
yj 
yj = 0 + β 1R j β
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distribution of income is –18.1 percentage points.
The same regression also may be run on
individual data (as in equation [5]), but replacing
Xi with Ri, with Ri being an individual’s relative
rank in the social-group distribution. In this case,
the data would be self-weighting and could be
estimated by ordinary least squares. 
Relative Index of Inequality
The SII discussed above is a measure of absolute
disparity. Dividing this estimated slope by the
mean population health, however, provides a
relative disparity measure, the Relative Index of
Inequality or RII (79):
[7]
where µ is mean population health and the SII is
the estimate of β1 from equation [6]. Its
interpretation is similar to the SII, but it now
measures the proportionate (in regard to the
average population level) rather than the absolute
increase or decrease in health between the highest
and lowest socioeconomic groups. In the income
and smoking example seen in Figure 12, the RII is
calculated as –18.1/24.6 = –0.74, indicating that a
RII = SII / 1 /βµ = µ 
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Figure 12. Income-Based Slope Index of Inequality for Current Smoking, NHIS, 2002
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Figure 12.  Income-Based Slope Index of Inequality for Current Smoking, NHIS, 2002
Average Smoking Rate = 24.6
SII = –18.1
RII = –0.74
y = 33.7 - 18.1x
move from the bottom to the top of the income
distribution is associated with a 74% decline in
the prevalence of smoking. Kunst and
Mackenbach (70) modified this definition of the
RII slightly by dividing the estimated health of the
hypothetical person at the bottom of the social-
group distribution by the estimated health of the
hypothetical person at the top of the social-group
distribution:
[8]
where β0 and β1 are defined as in equation [6].
From Figure 12, this is calculated as 33.7/(33.7 –
18.1) = 2.16, indicating that the rate of smoking is
2.16 times higher at the bottom of the income
distribution than at the top. Thus, the Kunst-
Mackenbach RII is more like a traditional relative
risk measure in that it compares the health of the
extremes of the social distribution, but it is
estimated using the data on all social groups and
is weighted to account for social-group sizes. As
noted above, the use of the SII and RII indices (as
well as the Health Concentration Index discussed
below) depends on having a social-group
classification scheme that is hierarchical. This
seems straightforward with respect to education
and income, but social-group classifications based
on occupation may be somewhat more
challenging because there inherently is more
ambiguity in the ranking of occupations (80). In
their international study of occupational
mortality differences, Kunst and Mackenbach (81)
note this difficulty as a possible explanation for
the lack of consistency of their results with those
of Wagstaff for the size of disparity in Finland
versus England and Wales (60).
Population Impact Measures
Population Attributable Risk
The Population Attributable Risk (PAR) and its
relative analogue, the PAR%, are longstanding
epidemiologic measures of the population burden
that is associated with differential health between
groups. Although typically applied to groups
defined by their exposure status (e.g., comparing
smokers with nonsmokers), it also may be applied
in the context of health differences between social
groups (poor vs. nonpoor). It is a summary of
differences between each social group’s health and
the health of the “best” group. For example, it
indicates the absolute (or relative, in the case of
the PAR%) aggregate health improvement that
would be obtained if all education groups had the
health of the healthiest education group. The
basic formulas for PAR and PAR% as health
disparity indicators (70) are:
[9]
[10]
where rpop is the rate in the total population and
rref is the rate of health or disease in the reference
group, typically the best-off social group. While
not immediately clear from the above formula,
the PAR% in fact is a population-weighted (by
social-group size) sum of the relative risks (RRs) for
each group (13) and also may be written as:
[11]
where pj is the group’s population share and RRj is
the relative rate of group j compared to the
reference group. To see this, note that we could
PAR% = 
pj (RRj – 1)Σ
pj (RRj – 1) + 1Σ
PAR% = 
rpop – rref
rpop
PAR = rpop – rref
RIIKM = = 
0 + SIIβ1β
0β
0 + β
0β
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substitute rj/rref for RRj and rref /rref for 1 in equation
[11] and multiply through by rref to get:
[12]
Because and , equation
[12] reduces to equation [10]. The PAR% varies
from 0 to 100 and is interpreted as the percent
improvement in the health of the total
population that would be achieved if all social
groups had the rates of health in the best-off
social group, a commonly used metric for
describing the impact of health disparities. For
example, Navarro argues that “the intervention
that would add the most years of life to the
populations of Spain or the USA (or, for that
matter, any other country) would be one that
would lead to all social classes having the same
mortality rates as those at the top” (65, page
1701). In the example in Figure 13, the
population average rate of cervical cancer would
be improved by 28% if all social groups had the
rate experienced by American Indians and Alaska
Natives.
Σ pj rref  = rrefΣ pj rj = rpop
PAR% = 
pj (rj – rref )Σ
pj (rj – rref ) + rrefΣ
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Figure 13. Example of the Population-Attributable Risk Percent
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Figure 13.  Example of the Population-Attributable Risk Percent
Cervical Cancer Incidence by Race and Hispanic Origin, 1996–2000
PAR% = (9.6 – 6.9) / 9.6 = 28.1%
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Source: SEER Cancer Statistics Review, 1975–2000.
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Index of Dissimilarity
The Index of Dissimilarity (ID) originally was
developed as a measure of residential segregation
of population groups (82). For example, in the
context of black-white segregation among
neighborhoods within a city, the ID measures the
proportion (using the relative version) or number
(using the absolute version) of blacks (or whites)
that would have to move to a different
neighborhood to achieve a racial distribution in
each neighborhood that was similar to that of the
city as a whole. As such, the ID is a summary
measure of the disparity between each
neighborhood’s racial composition and the racial
composition of the city as a whole. Similarly, in
the context of health disparity measurement, we
can think of the ID as a summary measure of the
disparity between, for example, each racial group’s
cancer rate and the cancer rate of the whole
population. In this case, the ID would be
interpreted as the number or proportion of cancer
cases that would have to be redistributed across
racial groups for each group’s cancer rate to be the
same as the rate in the whole population. The
formula for the relative ID with respect to health
is given in Wagstaff and colleagues (60) as:
[13]
where j indexes social groups, sjh is the jth group’s
share of health (e.g., share of all cancer cases), and
sjp is the jth group’s share of the total population.
According to Kunst and Mackenbach (70),
equation [13] is the relative version of the ID. The
relative ID compares how each social group’s
share of the population’s health compares with its
share of the total population and represents the
proportion of all cases (e.g., the proportion of all
cancer cases) that would have to be redistributed
across social groups so that each group has the
same rate as the total population. The absolute
version of the ID is calculated as:
[14]
where dj and pj are, respectively, the observed
number of cancer cases and the population of the
jth social group, rpop is the cancer rate in the total
population, so that pjrpop is the expected number
of cancer cases that would be observed if group j
had the same cancer rate as the total population.
One could also derive the absolute version of the
ID by multiplying the relative ID by the total
number of cases to determine the absolute
number of cases that need to be redistributed
across groups.
Table 1 on page 44 shows how one might
calculate the absolute and relative ID for
esophageal cancer incidence among working-age
(ages 25–64) racial groups during 1992–2000. A
comparison of columns (3) and (5) shows that the
share of cancer cases is lower than the share of
the SEER population for all groups except blacks,
who represent 13.5% of all esophageal cancer
cases but only 10.5% of the population. Similarly
for the absolute ID, a comparison of columns (2)
and (6) shows that if all groups experienced the
population rate of esophageal cancer, more cases
would be observed for all groups except for blacks.
The relative ID in this case is 3.4, which means
that 3.4% of the 17,186 cases of esophageal
cancer need to be redistributed across racial
groups to eliminate the racial disparity. In
absolute terms, this means redistributing 592
cases of esophageal cancer.
Absolute ID = | dj – pj rpop |2
1 Σ j = 1J
Relative ID = | sjh – sjp |2
1 Σ
j = 1
J
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Index of Disparity
The Index of Disparity, which we will abbreviate
as IDisp to distinguish it from the Index of
Dissimilarity (ID), summarizes the difference
between several group rates and a reference rate
and expresses the summed differences as a
proportion of the reference rate. This measure was
formally introduced by Pearcy and Keppel (30)
and is calculated as:
[15]
where rj indicates the measure of health status in
the jth group, rref is the health status indicator in
the reference population, and J is the number of
groups compared. Although in principle any
reference group may be chosen, the authors
recommend using the best group rate as the
comparison because that represents the rate
desirable for all groups to achieve. In this case, it
is not necessary to take the absolute value of the
rate differences because they all will be positive.
Other potential reference rates include the total
population rate, the average of group rates, or
some external target rate. A similar disparity
measure was developed by Gaswirth (83), but it
weights each group’s deviation from the best rate
by its population size, so that the disparity index
(U) becomes:
[16]
where pj is each group’s population size. In this
case, U is calculated as the weighted sum of the
health difference between each group and the
reference group. Similar to the Index of Disparity,
above, this value also can be expressed relative to
the health status of the total population, which
Gaswirth defines as G = U ÷ rpop. For example,
Gaswirth applied this disparity measure to rates of
mammography screening among non-Hispanic
white, non-Hispanic black, Hispanic, and Other
women ages 50–65 in the 2000 NHIS (83). The
overall screening rate was 78.6%, and Figure 14
(page 45) shows that white women had the
highest rates of screening (81%). The fraction of
the entire population that is “underserved” (U,
the shaded area in Figure 14) in this case is 2.04%,
and if the population screening rate were
increased by G = 2.6% and targeted to minority
women, the screening disparity would have been
eliminated. This measure has the additional
desirable feature of intuitive graphical
representation. Although not immediately clear
from equation [16], however, it should be noted
U =  pj (rj – rref )Σ
j = 1
J – 1
IDisp = | rj – rref | / J  /rref  x 100Σ
j = 1
J – 1( (
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Table 1. Incidence of Esophageal Cancer, Ages 25–64 by Race, 12 SEER Registries, 1992–2000
% of % of Cases if
T otal T otal No ID ID
Race Rate Cases Cases Population Population Disparity Relative Absolute
(1) (2) (3) (4) (5) (6) | (3) – (5) | | (2) – (6) |
American Indian/Alaska Native 5.7 133 0.8 2,316,609 1.3 226 0.5 93
Asian/Pacific Islander 8.7 1,648 9.6 18,850,492 10.7 1,835 1.1 187
Black 12.9 2,395 13.9 18,518,113 10.5 1,803 3.5 592
White 9.5 13,010 75.5 136,864,686 77.5 13,323 1.8 313
T otal 9.7 17,186 100.0 176,549,900 100.0 17,186 3.4% 592
that, in practice, when the reference group is the
group with the best rate, Gaswirth’s measure U is
equivalent to the PAR described above, and G is
equivalent to the PAR% because their calculations
are identical to the PAR and PAR%.
The Between-Group Variance
The variance is a commonly used statistic that
summarizes all squared deviations from a
population average. In the case of grouped data,
this is the Between-Group Variance (BGV), and it
is calculated according to the following formula
that squares the differences in group rates from
the population average and weights by their
population sizes:
[17]
where pj is group j’s population size, yj is group j’s
average health status, and µ is the average health
status of the population. The Between-Group
Variance may be a useful indicator of absolute
disparity for unordered group data because it
weights by population group size and is sensitive
to the magnitude of larger deviations from the
BGV =  pj ( yj – µ)
2Σ
j = 1
J
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Figure 14. Disparity in Mammography Screening Among Racial/Ethnic Groups, NHIS, 2000
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Figure 14.  Disparity in Mammography Screening Among Racial/Ethnic Groups, NHIS, 2000
Source: Gastwirth JL. Prev Med (forthcoming).
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Source: Gastwirth JL. Prev Med (forthcoming). 
population average. As an example, Figure 15
shows trends in age-adjusted lung cancer
mortality among U.S. Census divisions. 
The between-region variance in lung cancer
mortality in 1968 was 7.1 deaths per 100,000, but
in 1998 the BGV was 22.8 deaths per 100,000.
This larger absolute disparity in regional mortality
indicates divergent regional trends in lung cancer
over time (see Figure 15). The use of the variance
as a measure of disparity in economics sometimes
is discouraged because it is not “scale invariant.”
In other words, it is sensitive to absolute changes,
such as when everyone’s income doubles over
time. In this case, economists sometimes feel that
it is not desirable for the disparity measure also to
double, because relative inequality is maintained.
Although this may be an undesirable property
when dealing with income disparity, however, we
believe it is not necessarily a limitation for
discussing health disparity, in which we are
interested in absolute disparity burdens (84). From
a population health perspective, in which we may
be concerned with the health care implications of
increasing absolute disparity, we may care about
situations in which the absolute disparity
increases, and it is appropriate that the disparity
indicator reflect this increased concern. In this
case, then, using the variance (which squares the
absolute deviations from the population average)
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Figure 15. Age-Adjusted Lung Cancer Mortality by U.S. Census Division, 1968–1998
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Figure 15.  Age-Adjusted Lung Cancer Mortality by U.S. Census Division, 1968-1998
Source: NCHS. Compressed Mortality Files 1968-1998
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is consistent with a population health perspective.
In the example above of changes in regional lung
cancer disparity, the overall rates increase by 70%,
the coefficient of variation (the variance divided
by the mean) increases by 89% (indicating that
relative disparity increases as well), but the
variance increases by 320%. Thus, choosing this
as the measure of disparity reflects our concerns
with widening absolute differences among the
regions.
Measures of Average
Disproportionality
When describing health inequalities, public
health researchers and policy makers often use
what might be called the “language of
disproportionality.” For example, in the context of
arguing for the importance of measuring health
inequalities between socially meaningful
population groups, Braveman and colleagues
stated that “a disproportionate share of ill-health
and premature mortality is borne by the socially
disadvantaged” (51, page 233). Similarly, in
discussing health disparity trends, the Secretary of
Health and Human Services recently noted that
various racial/ethnic groups in the United States
“suffer an unequal burden of death and disease,
despite improvements in the overall health of the
general population over the past decade” (85).
The terms “disproportionate share” and “unequal
burden” are important descriptors because they
communicate the ethical notions inherent in the
collective concerns over health disparities. That is,
they capture the notion that it is unfair that some
groups experience more ill health than others; a
just distribution of health implies that ill health
should be experienced proportionately by
different social groups. A more explicit example
can be found in the Guidance for the U.S. National
Healthcare Disparities Report in which, in discussing
the disparity in cardiac catheterization rates
between blacks and whites, LaVeist states that the
“degree to which the predicted percentage of
catheterization deviates from the observed
percentage indicates the degree of disparity,” and
concludes that “African Americans received 67%
of the catheterizations that they should have
received, and whites received 14% more than
their share” (86, page 90). 
The quotations above make clear that health
disparity often is equated with the concept of
disproportionality. What is perhaps less clear is
that, in the context of the commonly used
“language of disproportionality,” there usually is
an implied reference group, which is the general
population. In fact, in the catheterization
example, LaVeist was arguing explicitly against
measuring health disparity using a relative
measure such as a risk ratio or odds ratio, because
doing so means using a particular social group (in
this case, whites) as the reference group, which
necessarily assumes that the rate in the reference
group is “most desirable.” Thus, he argued that
disparity measures that use whites as the reference
group would not be able to identify their “over-
utilization” of cardiac catheterization. The
intuitive ethical notion expressed in the
quotations above is that the amount of ill health
in social group j is far greater than would be
expected if ill health were evenly distributed with
respect to all J social groups. An even distribution
of ill health across J social groups implies that the
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number of individuals of social group j with
condition y is proportionate to group j’s share of
the total population, so that the rate of ill health,
Yj, in each of the j groups is exactly the same,
which would necessarily equal the rate in the
total population. Thus, the proportional
distribution of y among J groups implies that
(the mean of y) for all groups. 
This is an important point because many
commonly used measures of income disparity
(e.g., the Gini coefficient) and residential
segregation (e.g., the Index of Dissimilarity), some
of which currently are employed to measure
health disparities, may be expressed conveniently
as measures of average disproportionality (87–89).
For each social group j, we can define a health (or
ill health) ratio as the ratio of measure y in the jth
group to that of the mean of y for the whole
population, so that for each group. Note
that this makes such measures relative rather than
absolute disparity indicators. In this framework,
measures of disparity take the general form
[18]
where pj is group j’s proportion of the total
population and f(rj) is some disproportionality
function of the ratio . It should be clear
that equation [18] is a weighted disparity measure
because each group’s disproportionality function
f(rj) is multiplied by its population share pj.
Measures of this type of disparity indicator differ
because they implement different disproportion-
ality functions. Perhaps one of the appealing
features of such measures is that they provide a
rather direct correspondence between the
commonly used languages of health disparity in
terms of “disproportionality” with the
operationalization of the measurement. 
Figure 16 (page 49) depicts the concept of
“disproportionality” using data on all deaths in
the United States, by gender and education, for
the year 2000. Among males, those with less than
12 years of education bear a disproportionate
burden of all deaths, as they account for 24% of
all male deaths but account for only 12% of the
male population. Conversely, males with greater
than 12 years of education account for 55% of the
total population but only 32% of all deaths. The
level of disproportionality for females with less
than 12 years of education is slightly smaller.
Table 2 (page 49) shows some commonly
used statistical measures and their
disproportionality functions. Readers should note
that the measures differ only in how they express
the difference between shares of health and shares
of population. 
Entropy Indices
One class of disproportionality measures that
often is favored by economists are measures of
general entropy, developed by Henri Theil (90).
The example described below is for measuring the
disparity in BMI, which is a risk factor for a
number of cancer sites (91,92). Theil’s index gives
relatively more weight to the concentration in the
upper end of the health distribution and is
calculated (with grouped data) by summing the
product of each group’s BMI share of the
population’s total BMI and the natural log of each
rj = Y j / Y 
I =  pj f ( rj )Σ j
rj = Y j / Y 
Yj = Y 
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Figure 16. Example of the “Disproportionality” of Deaths and Population, by Gender and Education,
2000
Deaths Population Deaths Population
Figure 16.  Example of the “Disproportionality” of Deaths and Population, by Gender and Education, 2000
Source: NCHS. Deaths: Final Data for 2000, Natl Vit Stat Rep 2002;50(15).
Shares of All Deaths and Population, by Gender and Education, 2000
Males Females
>12 yrs >12 yrs
12 yrs 12 yrs
<12 yrs <12 yrs
32%
45%
24%
55%
32%
13%
33%
46%
21%
55%
32%
12%
Source: NCHS. Deaths: Final Data for 2000, Natl Vit Stat Rep 2002;50(15). 
Table 2. Commonly Used Disproportionality Functions
Index Name Disproportionality Function
Squared coefficient of variation (CV 2) (rj – 1)2
Gini index (G) Individual-level data: | ri – rj | / 2
Grouped data: rj(qj – Qj ), where qj is the proportion of the total population in groups less healthy than group j, andQj is the proportion of the total population in groups healthier than group j (i.e., pj + qj + Qj = 1)
Relative concentration index (RCI ) Same as for G, but groups are ranked by social group position instead of by health, so that qj is the proportion of
the total population in groups less advantaged than group j, and Qj is the proportion of the total population in
groups more advantaged than group j (i.e., pj + qj + Qj = 1) 
Theil index (T ) rj ln(rj )
Mean logarithmic deviation (MLD) ln(1/rj ) = –ln(rj )
Variance of log-health (VarLog) [ln rj – ∑(ln rj )]2
Note: Adapted from Firebaugh, 2003 (88).
group’s BMI share. For individual-level data, total
disparity in BMI measured by Theil’s index can be
written as
[19]
where pi is an individual’s population share
(which in the case of individual data will be 1/n,
so that pi = 1) and ri is the ratio of the
individual’s BMI to the population average BMI
(i.e., ). When the population of
individuals is arranged into J groups, Theil
showed that equation [19] is the exact sum of two
parts: between-group disparity and a weighted
average of within-group disparity:
[20]
where Tj is the disparity in BMI within group j.
The within-group component (the second term
on the right side of equation [20] is weighted by,
in this case, group j’s share of the total BMI,
because (where sj is the share of total
BMI) when the denominator for rj is the mean
BMI for the total population. More importantly,
the above decomposition also makes it clear that
it is possible to calculate between-group disparity
in BMI—the primary quantity of interest with
respect to social disparities in health—in the
absence of data on each individual. The only data
needed are the group proportions and the ratio of
the group’s BMI to the population average BMI.
Between-group disparity, however, may increase
because total disparity is increasing (i.e., both
between-group and within-group disparity are
increasing simultaneously). The primary
advantage of using additively decomposable
inequality measures is that they allow us to
determine not just whether between-group
disparity is increasing, but whether the share of
total disparity that is due to disparity between
groups is increasing or decreasing. Although this
measure has attractive qualities, the between-
group/within-group decomposition requires
continuous outcome data measurable in
individuals, so it is not clear whether this can be
applied to many relevant cancer outcomes that
are based on events (e.g., incidence, mortality, or
screening). Even for noncontinuous outcomes,
however, entropy indices easily can be used to
calculate between-group disparities in the absence
of individual-level data. For example, suppose that
instead of BMI we wanted to measure the
between-group disparity in obesity rates. We could
do this by calculating the first term on the right
side of equation [20] using only the data on each
group’s proportion in the population (pj) and the
group’s rate of obesity relative to the overall
population rate (rj)—data that are more likely to
be readily available. 
Measuring between-group inequality in BMI
in the above manner makes clear that changes in
the value of disparity over time are a function of
two quantities: changing group proportions and
changing social group BMI ratios. This is
important— in the case of obesity, for example—
because differentiating between these two
components of change has different implications
for obesity as a public health problem and may be
the result of very different social policies. If we
find that disparity is increasing but that the main
reason for the observed change is that the share of
the population among social groups at the tails of
the BMI distribution has increased, it simply
demonstrates that the inequality increase is due
primarily to the movement into and out of
pj x  r j = s j
T = pj rj ln (rj ) +          pj rjTjΣ j = 1J Σ j = 1J
ri = yi / Y
1n pj
sjsj ( (Σ
T = pi ri ln (ri )Σ i = 1N
50
different social groups—not to differentially
increasing rates of BMI within subgroups of a
social group. However, if we find that population
shares have remained relatively constant over
time but BMI disparity has increased because BMI
ratios are increasing, this implicates differential
sources of BMI change among particular groups—
which may then become the target of public
health intervention.
Atkinson’s Measure
Atkinson’s index actually is not a single index of
disparity but depends on specifying the relative
sensitivity of the index to different parts of the
distribution. One way of writing Atkinson’s index
is:
[21]
where pj and rj are again, respectively, the share of
population and the health ratio (relative to the
total population rate), as defined above. Clearly
with this index, the extent of disparity hinges on
specifying the parameter ε, which indicates the
degree of “aversion to disparity.” Larger values of ε
indicate stronger aversion to disparity, which also
may be interpreted as placing increased weight on
the least healthy groups. For example, if we are
particularly concerned about improving the
health of least-healthy individuals, we could make
the measure of disparity more sensitive to changes
in the bottom of the health distribution.
Gini Coefficient
The Gini coefficient summarizes social group
differences in, for example, BMI for the entire
population and can be thought of as a measure of
association between each social group’s share of
population, ranked by the group’s health and its
share of health. Its formula for individual data is
given above for the IID in equation [2], when
α = 2 and β = 1. Formally, the Gini coefficient is
the ratio of the area between the line of equality
in Figure 17 (page 52) and the Lorenz curve to the
total area of the triangle beneath the line of
equality (40). Because the Gini coefficient is a
function of the disproportionality between shares
of population and shares of health, one can see
from Figure 17 that health disparity increases as
the Lorenz curve moves further away from the
line of equality (i.e., as the disproportionality
between shares of population and shares of health
increases).
Concentration Index
The Concentration Index (CI) is calculated
similarly to the Gini index, but it results from a
bivariate distribution of health and social-group
ranking. In the same way that the Gini coefficient
is derived from the Lorenz curve, the CI is derived
from a concentration curve, where the population
is ordered first by social-group status (rather than
by health status, as for the Gini), and the
cumulative percent of the population then is
plotted against the group’s share of total ill
health. When the y-axis is the share of ill health,
this results in the Relative Concentration Index
(RCI); however, an Absolute Concentration Index
(ACI) also may be derived by plotting the
cumulative share of the population against the
cumulative amount of ill health (i.e., the
cumulative contribution of each subgroup to the
mean level of health in the population). Figure 18
(page 53) gives a graphical representation of a
relative concentration curve. Note the similarity
with the Lorenz curve drawn in Figure 17 to
illustrate the Gini coefficient. The two curves and
A = 1 – [ pj rj1 –  ]     ,   >  01 / [1 –    ]Σ j = 1J ε εε
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thus the Gini coefficient and the RCI are
calculated similarly, the only difference being the
way in which social groups are ordered. In the
case of the Gini coefficient, social groups are
ordered by their health status (lowest to highest),
regardless of their socioeconomic group ranking;
for the RCI, social groups are ordered by their
ranking in terms of, for example, years of
education, regardless of their health status. It is
important to note that, because the
Concentration Index incorporates information
on both health and social-group status, the
concentration curve may lie either above or 
below the line of equality. The general formula for
the Relative Concentration Index (RCI) for
grouped data is given by Kakwani and colleagues
(93) as:
[22]
where pj is the group’s population share, µj is the
group’s mean health, and Rj is the relative rank of
the jth socioeconomic group, which is defined as:
[23]
where p
γ
is the cumulative share of the population
up to and including group j, and pj is the share of
the population in group j. Rj essentially indicates
the cumulative share of the population up to the
midpoint of each group interval, similar to the
categorization of the Slope and Relative Index of
Rj = pγ –   p jΣ j = 1J 21
RCI =    [ pj   j Rj]–  1Σ j = 1Jµ µ2
52
Figure 17. Representation of the Gini Coefficient of Disparity
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Figure 17.  Representation of the Gini Coefficient of Disparity
Line of Equality
Lorenz Curve
Inequality above. In fact, the RCI has a specific
mathematical relationship with the RII (60):
[24]
where R is the relative rank variable identified in
equation [23]. Thus, the SII/RII and the ACI/RCI
will produce the same rank ordering of health
inequality over time but will differ in scale. The
absolute version of the Concentration Index (ACI)
is calculated by multiplying the RCI by the mean
rate of the health variable:
[25]
where µ is the mean level of health in the
population. It also is worth pointing out that,
when using continuous health outcomes, the RCI
is unbounded and takes minimum and maximum
values of –1 and +1, but when using binary health
outcomes, the possible values of the RCI are
limited by the mean (e.g., the prevalence) of the
distribution (94). Adam Wagstaff shows that, for a
given nonzero mean of a binary variable (µ), the
minimum of the RCI is [ ] and the
maximum is [ ], with n being the
sample size. This of course has implications for
analyses that compare the extent of
socioeconomic inequality in health between areas
or outcomes with very different levels of average
health, and one potential strategy for facilitating
comparisons is to normalize the Concentration
Index by dividing it by its bound (95). 
1 – µ + (1/n)
µ – 1 + (1/n)
ACI = µRCI
RCI = 2var(R)RII
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Figure 18. Representation of the Health Concentration Curve
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Figure 18.  Representation of the Health Concentration Curve
Disparities Favor
the “Worse-off”
No Social Disparity
Disparities Favor
the “Better-off”
Table 3 shows a simple example of how the
RCI and ACI are calculated using equations [22]
and [25] with grouped data using lung cancer
mortality rates by educational attainment. One
can see that lung cancer mortality rates decrease
with increasing education, and the negative value
of both indices shows that the disparity in lung
cancer mortality favors the better educated.
One of the reasons the ACI and RCI (and, by
extension, the SII/RII indices) are favored by some
is that they “reflect the socioeconomic dimension
to inequalities in health” (60, page 548). That is, a
downward health gradient (such that health
worsens with increasing social-group rank) results
in a positive index, whereas an upward health
gradient results in a negative index. For example,
if the data in Table 3 were reversed so that lung
cancer mortality rates for those with <12 years of
education were 16.9 and the rates were 49.8 for
those with >12 years of education, the RCI then
would be calculated as 0.114 and the ACI as
4.873, indicating that lung cancer mortality
actually favors the less educated. This sensitivity
to the direction of the health gradient is not a
property of other disproportionality measures,
such as the Gini coefficient and the Index of
Dissimilarity, because they do not depend on the
strict ordering of social groups.
This undoubtedly is an advantage of the RCI,
but, as with all disparity measures, it also may be
seen as a disadvantage. Because of its sensitivity to
socioeconomic gradients in health, the RCI may
not register any disparity when health is not
ranked directly by social group. Thus, when a
social group ranked in the middle of a hierarchy
bears a disproportionate burden of ill health, the
RCI well may register this as zero disparity. This is
not just a theoretical limitation of the RCI. For
instance, age-adjusted rates of breast cancer deaths
(per 100,000) in the United States in 1998 were
20.0 among those with less than a high-school
education, 28.4 among those with a high-school
education, and 22.0 among those with at least
some college education (9). If the respective shares
of the population in each of the education groups
were approximately 38.8%, 20%, and 41.2%, the
RCI would be virtually zero, indicating no
educational mortality disparity; yet those with a
high-school education will contribute roughly
40.3% of breast cancer deaths. A reasonable case
could be made that a disproportionate burden of
breast cancer falls on the high-school-educated
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Table 3. Educational Disparity in Lung Cancer Mortality, 1999
Education Rate per 100,000 Population Share Midpoint (%) CI
<12 years 49.8 0.128 0.064 0.408
12 years 41.0 0.327 0.292 3.913
>12 years 16.9 0.545 0.728 6.699
T otal 29.0 1.0 1 1.020
Relative Concentration Index → –0.240
Absolute Concentration Index → –6.959
Note: Rates are for persons aged 25–64 years and exclude the following states: Georgia, Kentucky, Rhode Island, and South Dakota. Rate data are from
DATA2010…the Healthy People 2010 Database, April 2004 edition, and SEER*Stat. Population data are from NCHS, Deaths: Final Data for 1999: Table VII.
(using this categorization of education), but the
RCI would not reveal this pattern. This pattern of
the worst health among those in the middle social
group is not simply an artifact of breast cancer as
an unusual cause of death. This pattern also is
seen for colorectal and prostate cancers and
melanoma as well where rates across ordered
social groups are not simple gradients. 
We use the breast cancer example not
necessarily to suggest that the RCI is a poor index
for measuring social-group disparities in health,
but rather to emphasize that all disparity
measures have advantages and disadvantages that
should be considered when selecting and
interpreting a disparity index; no summary
disparity measure should be used as a substitute
for detailed inspection of the health status
indicators for each social group via tables and
graphs.
Wagstaff also derived a method for
incorporating a society’s degree of aversion to
disparity into the RCI, which he calls the
“extended” Concentration Index (96). The
aversion parameter changes the weight attached
to the health of different socioeconomic groups in
a manner similar to the Atkinson Index described
above. The formula for this extended version of
the RCI for grouped data is: 
[26]
where ν is the “aversion parameter,” and the other
quantities are defined as in the RCI in equation
[22] above. Setting ν = 1 weights every group’s
health equally (i.e., complete indifference to
inequality), and setting ν = 2 gives the standard
RCI defined above. As ν increases, the weight
attached to the health of lower socioeconomic
groups increases, and the weight attached to the
health of higher socioeconomic groups decreases.
Table 4 (page 56) shows the effect of varying the
weight placed on the health of the less-educated
groups for the disparity in current smoking in the
state of Michigan in 1990 and 2002. The two
rightmost columns are the calculated RCIs, with
differing aversions to disparity. Setting ν = 2 gives
the standard RCI of –0.129, indicating that the
disparity in current smoking favors the better
educated. Increasing the weight placed on the
health of the less-educated groups in 1990 results
in only a marginal increase in the measure of
disparity to –0.178, most likely because the rate of
smoking among those with <8 years of education
actually is quite low. The major effect of the
differential weighting of the RCI can be seen in
the disparity change from 1990 to 2002; in 2002,
the standard RCI(2) was –0.19, a disparity increase
of 48.5%, and the more bottom-sensitive RCI(4)
was –0.32, indicating a much larger 81% increase
in the relative education disparity in smoking.
The reason the increase in disparity is so much
larger for RCI(4) is that, although rates of smoking
decreased overall and in every other education
category, the estimated rate of current smoking
actually increased among the least-educated
group. This example shows how we can
incorporate an ethical judgment (particular
concern about the health status of the least
educated) into a measure of health disparity.
RCI(v) = pj µj (1  –  R j )
v – 1Σ
j = 1
J
µ
vpj (1  –  R j )
v – 1Σ
j = 1
J
v –
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Combining Health Disparity and Average
Health
As we emphasized in the above discussion of
relative and absolute health disparities, the goals
of Healthy People 2010 are couched specifically in
terms of both health disparities and average levels
of population health. Thus, we also may be
interested in investigating potential ways to
incorporate both average health and health
disparity into a single summary measure. One
potential measure, created by Adam Wagstaff, is
called the Health Achievement Index or HAI (96).
The Health Achievement Index
The HAI in some respects is similar to the ACI
described above, but combines disparity and
average health by essentially subtracting the
Absolute Concentration Index from the
population’s average health, creating a “disparity-
discounted” level of average health. The formula
for the HAI is (96):
[27]
where µ is the population’s average health and
RCI(ν) is the extended Relative Concentration
Index defined above. Thus, applying equation
[27] to the data on the average rate and
educational disparity (using RCI[2]) in smoking
in Michigan, the HAI(2) for Michigan in 1990
is 0.29 x (1 – [–0.129]) = 0.33, and is 0.24 x
(1 – [–0.191]) = 0.29 in 2002. Clearly, if RCI = 0,
then the HAI is equal to the population average
rate of health, and the larger the RCI, the further
away the HAI is from the population average—a
kind of “disparity penalty” applied to the
population average rate. In this sense, the HAI is
HAI(v) = µ 1 – RCI(v)
= µ – ACI(v)
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Table 4. Example of Extended Relative and Absolute Concentration Index Applied to the Change in
Educational Disparity in Current Smoking, Michigan, 1990 and 2002
Education Population (%) % Smokers Midpoint (%) RCI ( ν = 2) RCI ( ν = 4)
1990
<8 years 4.5 27.2 2.3 0.006 0.011
9–11 years 12.4 39.9 10.7 –0.082 –0.131
12 years 36.9 33.3 35.4 –0.068 –0.057
13–15 years 27.3 29.6 67.5 –0.003 –0.001
16+ years 18.9 13.6 90.6 0.019 0.000
T otal 100.0 29.1 –0.129 –0.178
ACI = –3.75 ACI = –5.16
2002
<8 years 2.0 36.6 1.0 –0.021 –0.041
9–11 years 7.8 36.3 5.9 –0.073 –0.130
12 years 31.4 31.3 25.5 –0.137 –0.152
13–15 years 29.6 24.5 56.0 –0.003 –0.001
16+ years 29.2 12.2 85.4 0.042 0.002
T otal 100.0 24.2 –0.191 –0.321
ACI = –4.63 ACI = –7.77
Note: Data is for current smoking and is drawn from the 1990 and 2002 Behavioral Risk Factor Surveillance System (BRFSS).
not exactly a measure of health disparity but a
potentially useful way of capturing both
aggregative (Healthy People 2010 Goal 1) and
disparity (Healthy People 2010 Goal 2) concerns in
a single summary measure, at least with respect to
ordered social groups. For example, while both
relative and absolute education disparity in
smoking increased in Michigan over the 12-year
period (i.e., education disparity unambiguously
increased, see Table 4), health achievement
actually improved because almost all education
groups experienced a decrease in the rate of
smoking (in this case, health “achievement”
increases as the population rate of smoking
decreases). 
Two populations (or time periods) therefore
might have the same value on the Achievement
Index but differ greatly on both average health
and the extent of health disparity. For example, in
Figure 19 (page 58) the relative concentration
curves for education disparity in obesity in New
York State are plotted for 1990 and 2002. Because
the 2002 curve is beneath the 1990 curve for every
education group, we can unambiguously declare
that relative education inequality in obesity in
New York decreased from 1990 to 2002. The
standard RCIs summarizing the two curves also
reflect the decrease in disparity, going from –0.284
in 1990 to –0.125 in 2002. As was mentioned at
the outset, however, we do not believe that
disparity is all that matters. We also are concerned
with the average health of the population, and
the estimated obesity rate in New York more than
doubled over this period, from 9.8% in 1990 to
20.6% in 2002. Figure 20 (page 59) shows the
absolute concentration curves, which clearly
reflect the increase in obesity among all groups.
Inspection of the education-group-specific obesity
rates reveals that, in general, the education
disparity in obesity declined because of increasing
obesity rates, particularly among the middle- and
better-educated groups. When we incorporate the
adverse changes in overall population rates of
obesity with the changes in disparity, the change
in the Health Achievement Index (for which
larger values are worse because the health
outcome, obesity, is negative) indicates that
things became worse, having increased from 0.13
in 1990 to 0.23 in 2002.
57
58
100
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Figure 19.  Relative Concentration Curves for Educational Disparity in Obesity in New York State, BRFSS, 1990 and 2002
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Figure 19. Relative Concentration Curves for Educational Disparity in Obesity in New York State, BRFSS,
1990 and 2002
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Figure 20.  Absolute Concentration Curves for Educational Disparity in Obesity in New York State,  BRFSS, 1990 and 2002
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Figure 20. Absolute Concentration Curves for Educational Disparity in Obesity in New York State, BRFSS,
1990 and 2002
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Choosing a Suite of Health Disparity Indicators
Monitoring progress toward the elimination of
disparities in cancer-related health objectives
involves a number of ethical, conceptual, and
methodological issues that must be given careful
consideration to answer the question of which
measure or measures should be employed to
monitor progress toward the elimination of health
disparities between social groups. 
One possibly useful way to approach the
measurement of health disparity is to consider a
sequence of methodological approaches. 
• First, we cannot emphasize enough the close
inspection of the underlying subgroup-specific
health outcomes (rate or prevalence, etc), either
via tabular or graphical inspection. This is likely
to reveal important population health patterns,
highlight the situation of specific subgroups of
interest, and lend an understanding of any
underlying heterogeneity that a summary
measure of health disparity may not emphasize. 
• Next, consider the relevant question that is to
be answered. If one is interested in the health
disparity between two particular groups—for
example, the trend in the disparity between black
and white males in lung cancer mortality—then
the use of a pairwise comparison of trends is
sufficient. 
• Even for assessing health-disparity trends
between two groups using a pairwise comparison,
we recommend using both an absolute and a
relative disparity measure. This is especially
warranted when making long-term comparisons
that may involve steep declines or increases for all
social groups. Although the relative disparity
measure gives some indication of the progress (or
lack thereof) one group is making, regardless of
the actual level of health, absolute disparity
measures provide a context in which to judge the
public health impact of relative health disparities.
Thus, we would argue for the primacy of the
absolute indicator of disparity. Efforts to improve
public health often rely on the absolute burden of
disease; thus, the absolute disproportionality in
health disparity also should have priority. This is
the case especially when comparing the size of
social-group disparity across different cancer
outcomes and risk factors. We also understand,
however, that this in no way excludes particular
cases in which the relative inequality may be
judged—for other equally good reasons—to be of
high priority despite low levels of dispropor-
tionate absolute burden. For instance, the two-
fold relative disparity in cervical cancer between
black and white women may be judged to be
especially important because it is a health
disparity that is almost entirely avoidable through
the routine use of screening, even though the
absolute disparity involves only about 5 deaths
per 100,000.
• If one is interested in monitoring the health
disparity trend across the entire range of
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subgroups within a social-group category—for
example, across all racial/ethnic groups rather
than comparing, say, blacks and whites—or if the
social-group category has many subgroups—such
as the disparity across the 50 U.S. states—then
summary measures of health disparity are
warranted. The first decision involved in choosing
a summary measure is dictated by whether or not
the social groups in question have a natural
ordering.
Summary Indicators
Ordered Social Groups
If the social group does have a natural ordering, as
with education and income groups, then we
recommend using either the Absolute
Concentration Index (ACI) or Slope Index of
Inequality (SII) as a measure of absolute health
disparity, and the Relative Concentration Index
(RCI) or the Relative Index of Inequality (RII) as a
measure of relative disparity. The major reasons
for choosing these particular measures are that
• they account for changes in the underlying
population distributions in the social groups over
time and use information across the entire range
of social groups;
• they are flexible enough to allow different
levels of aversion to disparity to be incorporated;
and 
• they are sensitive to the direction of the social
gradient in health.
Although this last criterion mainly is what
distinguishes these measures from other summary
measures of inequality, such as the Gini
coefficient or the Index of Dissimilarity, we would
also reemphasize that, if the social groups in the
middle of the distribution (e.g., those with a high-
school education as opposed to those with less or
more education) experience a disproportionate
burden of ill health, our selected measures may
indicate that no disparity exists when it in fact
could be argued otherwise. Of course, if the
sequence laid out above is adhered to, then Step
1—a simple and careful inspection of the basic
subgroup data—should reveal this. 
This is part of the “cost” of using summary
measures of disparity, but in this case a
comparison of the RCI or RII with another
measure of disproportionality that is not strictly
sensitive to health gradients, such as the Gini
coefficient or Theil index, may reveal important
information about the social distribution of
health. Lastly, because the RCI has a mathematical
relationship to the RII, and the ACI has such a
relationship to the SII, they always will result in
the same rank ordering of health distributions.
That being said, one additional desirable feature
of the ACI and RCI is the ability to graph their
associated health concentration curves. Although
the ability of any summary measure of health
disparity to communicate important information
about disparity trends to health policy makers
may be limited, the ACI and RCI may serve this
purpose better than the RII and SII.
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Unordered Social Groups 
Our recommendations for health disparity
measures for ordered groups restate the
recommendations of earlier reviews of health
disparity measures (60,70). In the context of the
Healthy People 2010 goals, however, groups with a
natural ordering represent only a small number of
the social groups across which we want to
eliminate disparities in cancer-related health
outcomes. Therefore, we also need to think about
disparity measures that can be applied to
unordered social groups. Again, we would
emphasize choosing a summary measure of health
disparity only when one is interested in
monitoring the extent of disparity across more
than two or three social groups. For comparisons
of two specific groups, there is no substitute for
simple pairwise measures of absolute and relative
disparity. 
If comparisons across multiple unordered
groups are needed, we recommend the Between-
Group Variance (BGV) as a summary of absolute
disparity and the general entropy class of
measures developed by Henri Theil as summary
measures of relative disparity (more specifically,
the Theil index and the Mean Log Deviation). An
important reason for choosing the Between-Group
Variance and the entropy-based measures is that
they are disparity measures that can be
decomposed perfectly into between-social-group
and within-social-group components, given a
continuous health outcome. This cannot be said
of other measures, such as the Gini coefficient
and Atkinson’s measure (97,98). The ability of the
variance and the entropy class of disparity
measures to decompose disparity is important
because it allows one to look at any number of
cross-classified social groups, whether ordered or
not. For example, race and income, or gender and
education, can be examined jointly to assess the
trend in disparity between certain dimensions of
society. We could look first, for example, at the
trend in between-race disparity in cancer survival
time and see whether the disparity is increasing or
decreasing. We then could look at the disparity
between race-education groups over time. It may
be that, while the between-race disparity is
decreasing, educational disparities within race
groups actually are increasing. In addition, the
entropy-based measures also can be decomposed
to investigate the relative effects of changing
social group distributions versus changing health
distributions. This is important because both of
these aspects of the population constantly are
changing over time. Understanding the relative
impact of health changes versus compositional
changes in social groups is important for
understanding the prospects for intervening to
eliminate health disparities. Thus, because of their
decomposition properties, the entropy measures
may be useful tools for describing and
understanding the stratification of cancer-related
health outcomes across time.
Our recommendation for measures of health
disparity, for both ordered and unordered social
groups, come from explicitly adopting the
population health perspective toward monitoring
health disparities. By taking a population health
perspective, we emphasize using the total
population as the reference group for measuring
health disparity, weighting social groups
according to the number of individuals they
represent, and examining both absolute and
relative disparities in health. By doing so, we are
able to account for changes in the distribution of
individuals across social groups over time, a fact
that has clear population health consequences,
and we also are able to express health disparities
in a way that emphasizes their overall burden on
population health.
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Table 5. Summary Table of Advantages and Disadvantages of Potential Health Disparity Measures
Absolute All Reflect Social Inequality
or Reference Social SES Group A version Graphical
Disparity Measure Symbol Relative Group Groups Gradient W eighting Parameter Analogue
T otal Disparity
Inter-Individual Difference IID Variable ATBOa No No No Yes No
Individual-Mean Difference IMD Variable Average No No No Yes No
Social Group Disparity
Absolute Difference AD Absolute Best No Yes No No Yes
Relative Difference RD Relative Best No Yes No No Yes
Regression-Based Relative Effect RRE Relative Best Yes Yes Nob No Yes
Regression-Based Absolute Effect RAE Absolute Best Yes Yes Nob No Yes
Slope Index of Inequality SII Absolute Average Yes Yes Yes No Yes
Relative Index of Inequality RII Relative Average Yes Yes Yes No Yes
Index of Disparity IDisp Relative Best Yes No No No No
Population Attributable Risk PAR Absolute Best Yes No Yes No Yes
Population Attributable Risk% PAR% Relative Best Yes No Yes No No
Index of Dissimilarity ID Absolute Average Yes No Yes No Yes
Index of Dissimilarity% ID% Relative Average Yes No Yes No No
Relative Concentration Index RCI Relative Average Yes Yes Yes Yes Yes
Absolute Concentration Index ACI Absolute Average Yes Yes Yes Yes Yes
Between-Group Variance BGV Absolute Average Yes No Yes Yes No
Squared Coefficient of Variation CV 2 Relative Average Yes No Yes No No
Atkinson’s Measure A Relative Average Yes No Yes Yes No
Gini Coefficient Gini Relative Average Yes No Yes No Yes
Theil Index T Relative Average Yes No Yes Yes No
Mean Log Deviation MLD Relative Average Yes No Yes Yes No
Variance of Logarithms VarLog Relative Average Yes No Yes No No
aAll those better off.
bIn the case of regression-with grouped data.
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Appendix: Example Analyses
This appendix presents two examples of how to
measure and monitor cancer-related disparity
trends using the suite of indicators and
measurement strategy outlined in the
recommendations above. The examples are taken
from the cancer-related objectives outlined in
Healthy People 2010 and are illustrative rather than
substantive analyses. The first example assesses
the trend in the prevalence of mammography
screening among education groups and
emphasizes disparity measures for ordered social
groups. The second example assesses the trend in
colorectal cancer mortality among racial groups
and highlights the use of disparity measures for
unordered social groups.
Example 1: Educational Disparity in
Mammography Screening, 1990–2002
This example is based on self-reported data on the
use of mammography screening from the Centers
for Disease Control and Prevention’s (CDC)
Behavioral Risk Factor Surveillance Survey
(BRFSS), an annual state-based telephone survey
of adults. Although perhaps not the optimal
source of data on routine cancer screening
because of its high rate of nonresponse, the BRFSS
may be used to approximate a nationally
representative sample (99), and its annual
administration and timely reporting of results
make it useful for illustrating disparity trends.
Method
• Step 1: Inspect the underlying subgroup data.
Figure A1 (page 66) shows the prevalence of
women over age 40 who reported having not
received a mammogram in the past 2 years for
five education groups. From the chart, two things
are immediately clear. First, all groups are
improving over time (i.e., the proportion of
women not having mammograms is declining),
and some groups have actually achieved the
Healthy People 2010 target rate of 30%. Second,
there is a graded relationship between the
proportion of women not having a mammogram
in the past 2 years and years of education—
women with fewer years of education are less
likely to have received a mammogram in the past
2 years.
• Step 2: Determine the disparity question to be
answered. For this example, we are concerned
about whether the extent of disparity in
mammography screening across all education
groups is increasing or decreasing. As a result, we
will use a summary measure of health disparity.
Suppose, however, that there had been a
dedicated effort to increase the rate of screening
among women with a high-school education. We
then might be more interested in the question of
whether the effort had narrowed the gap in
screening between women with the highest 
screening rates (college-educated) and high-
school-educated women. In this case, a summary
measure might mask an important change in this
particular subgroup, so we would use a simple
pairwise comparison of the absolute and relative
difference in screening. 
• Step 3: Choose a summary measure of health
disparity. Having decided to use a summary
measure, the choice of a measurement tool
hinges on whether the social groups in question
have a natural ordering. In the case of years of
education, there clearly is a natural ordering, so
we will choose the Relative Concentration Index
(RCI) as a measure of relative disparity and the
Absolute Concentration Index (ACI) as a measure
of absolute disparity. Both measures are
calculated for two levels of disparity aversion,
ν = 2, which gives the standard RCI and ACI (96),
and ν = 4, which gives additional weight to the
health of the lower-educated groups. 
Results 
For the beginning and end of the period
1990–2002, Table A1 (page 68) shows the
prevalence of not having a mammogram in the
past 2 years (µj) and the population proportion
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Figure A1. Proportion of Women Age 40 and Over Who Did Not Receive a Mammogram in the Past
2 Years by Educational Attainment, 1990–2002
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Figure A1.  Proportion of Women Age 40 and Over Who Did Not Receive a Ma mogra  in 
                    the Past 2 Years by Educational Attainment, 1990-2002
Source: CDC, Behavioral Risk Factor Surveillance Surveys 1990–2002.
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<8y 9–12y 12y 13–15y 16+y 2010 Target
Source: CDC, Behavioral Risk Factor Surveillance Surveys 1990–2002.
(pj) for each group. The relative ranking of each
interval (Rj), based on the midpoint of the
cumulative population distribution, is derived by
applying equation [23] above; thus, for the group
with 9–11 years of education, the relative ranking
is 0.09 + (0.5 x 0.14) = 0.17. This particular
group’s contribution to the RCI(2) is calculated
using equation [26] above as [2 x 0.14 x
(1 – 0.17)(2–1)] – [(2/41.0) x 51.6 x 0.14 x
(1 – 0.17)(2–1)] = –0.0618. Applying equation [26]
across all education groups gives the overall
RCI(2), which for 1990 = –0.1045. To give this
value some perspective, Zhang and Wang, using
income as a measure of socioeconomic position
and using data from the National Health and
Nutrition Examination Survey (NHANES III) (100),
report a relative Concentration Index of –0.055
for obesity. Because in this case the outcome is the
proportion of women not having a mammogram,
the negative sign of RCI(2) indicates that the
disparity favors better-educated women. A positive
RCI(2) in this case would have indicated that
disparity actually favors less-educated women.
Additionally, the effect of increasing the aversion
to disparity becomes readily apparent as the value
of the RCI in 1990 increases (from –0.10 to –0.19)
when the aversion to disparity increases twofold.
Our preferred measure of absolute disparity for
ordered social groups, the Absolute Concentration
Index (ACI), also is displayed in Table A1 and is
calculated from equation [27] above; for 1990
ACI(2) = 41.0 x (–0.1045) = –4.2. 
Comparing 1990 and 2002 it appears that, as
measured by the standard ACI (i.e., with ν = 2),
absolute disparity in mammography screening
declined substantially over those 12 years—a
43.9% reduction. Relative disparity showed only
slight improvement, with the HCI(2) declining
only 2.6%. Note that, with an increased aversion
to disparity (ν = 4), relative disparity actually
shows a slight increase (from –0.191 to –0.201),
while absolute disparity still declines (from –7.8 to
–4.7). Although this indicates virtually no change
in relative disparity, Figure A2 (page 69) shows
that, when calculated annually, relative disparity
was not consistent over the entire period. As the
prevalence of not having a mammogram fell
faster for the less-educated groups in the first half
of the 1990s, both absolute and relative disparity
declined (i.e., the best possible scenario). As
screening rates tapered off among the less-
educated groups, however, relative disparity
increased in the latter half of the 1990s,
eventually returning to the 1990 level by 2002.
Note also that two components of the RCI and
ACI were changing over the period of observation:
the prevalence rates and the population shares in
each education group. Most notably, the share of
the population with less than 12 years of
education—the groups with the highest
prevalence rates—declined from 24% (0.09 among
those with <8 years plus 0.14 for those with 9–11
years) to 14% (0.06 + 0.08). Because the RCI is a
population-weighted index, this change alone
(i.e., in the absence of any change in prevalence
rates) would serve to decrease the level of
disparity. Thus, a logical next step in analyzing
the disparity trend might be to decompose the
change in disparity to determine how much of
the change is due to declining prevalence rates
and how much is due to upward shifting of the
education distribution. We will not go through
the decomposition steps here, but we would re-
emphasize that such decomposition techniques
are likely to be useful in understanding the
sources of changes in health disparities.
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Thus, by using two summary measures of
disparity, we can make some generalization about
the trend in the education-related disparity in
mammography screening. Between 1990 and
2002, the relative disparity between education
groups remained essentially the same, but the
absolute disparity declined because the prevalence
of not having a mammogram declined in all
education groups, with the largest absolute
declines having occurred among the less-educated
groups. Thus, we would argue that the population
health burden associated with the education-
related disparity in mammography screening has
decreased. This, of course, is not the best possible
scenario, but we would argue that the disparity
situation is better in 2002 than it was in 1990. 
Lastly, we would re-emphasize that our
conclusion about the socioeconomic disparity
trend in mammography reflects a population
health perspective on health disparities. Because
we were concerned about the disparity across all
education groups, we chose two population-
weighted summary disparity measures. The results
obtained by the application of these measures
may or may not be consistent with other disparity
measures that reflect concern about a different
dimension of disparity.
Table A1. Example of Relative and Absolute Concentration Index Applied to the Change in Educational
Disparity in Mammography, 1990 and 2002
Population Cumulative
Y ears of Rate Share Share Midpoint RCI ( ν = 2) RCI ( ν = 4)
Education [µj] [pj] [pγ ] [Rj] ( ν) Σ [pj (1 – Rj ) ( ν – 1) ] – ( ν/ µ) Σ [pj µj (1 – Rj ) ( ν – 1) ]
1990
<8 years 54.2 0.09 0.09 0.05 –0.0583 –0.1059
9–11 years 51.6 0.14 0.24 0.17 –0.0618 –0.0860
12 years 41.1 0.36 0.60 0.42 –0.0012 –0.0008
13–15 years 38.0 0.22 0.82 0.71 0.0093 0.0016
16+ years 29.0 0.18 1.00 0.91 0.0095 0.0002
T otal 41.0
Relative Concentration Index → –0.1025 –0.1910
Absolute Concentration Index → –4.1963 –7.8229
2002
<8 years 33.3 0.06 0.06 0.03 –0.0452 –0.0854
9–11 years 33.7 0.08 0.14 0.10 –0.0610 –0.0998
12 years 24.7 0.34 0.47 0.30 –0.0214 –0.0208
13–15 years 22.1 0.27 0.74 0.61 0.0134 0.0042
16+ years 18.6 0.26 1.00 0.87 0.0144 0.0005
T otal 23.6
Relative Concentration Index → –0.0998 –0.2014
Absolute Concentration Index → –2.3549 –4.7493
Note: Data is for the proportion of women over 40 who did not have a mammogram within the past 2 years and is drawn from the 1990–2002 Behavioral Risk
Factor Surveillance System.
Example 2: Racial Disparity in Colorectal
Cancer Mortality, 1990–2002
Our second example concerns rates of colorectal
cancer mortality from 1990 to 2002 among four
racial groups: American Indian/Alaska Natives,
Asian/Pacific Islanders, blacks, and whites. The
data for this example come from NCI’s SEER
Program (www.seer.cancer.gov). There are several
limitations to this example that should be
recognized. First, it is not possible with current
data to analyze longer trends for mutually
exclusive detailed racial/ethnic groups because
many states did not have complete information
on ethnicity in death certificate data. Second,
there is great heterogeneity of cancer risk among
subgroups of American Indian/Alaska Natives and
Asian/Pacific Islanders that is not reflected in this
simple example because we are forced to combine
these groups. Similar issues of lack of
homogeneity arise in comparing groups defined
by ethnicity and by various social, economic, and
geographic factors.
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Figure A2. Trends in Education-Related Disparity and Prevalence for the Proportion of Women Age 40
and Over Who Did Not Receive a Mammogram in the Past 2 Years, 1990–2002
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Figure A2.  Tre ds in Education-Related Disparit  d Prevalence for the Proportion of Women Age 40 and
                   Over Who Did Not Receive a Mammogram in the Past 2 Years, 1990-2002
Source: CDC, Behavioral Risk Factor Surveillance Surveys 1990–2002. 
*Note: Question not asked in 2001.
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Method
• Step 1: Inspect the underlying subgroup data.
Figure A3 (page 71) shows trends among those
aged 45–64 years for colorectal cancer mortality
for the four racial groups. Blacks have the highest
rates of colorectal cancer mortality, followed by
whites, and then by American Indian/Alaska
Natives and Asian/Pacific Islanders, both of whom
have similar mortality rates that actually are near
the 2010 age-adjusted target rate. Both blacks and
whites experienced relatively steady declines in
colorectal cancer mortality rates during the 1990s
(although the decline in black rates seems to slow
down after the mid-1990s), but the rates among
other groups remained somewhat steady,
hovering near the 2010 target rate. 
• Step 2: Determine the disparity question to be
answered. Although a number of interesting
pairwise comparisons could be made, in the spirit
of the Healthy People 2010 goals we are interested
in the extent to which progress is being made
toward the elimination of racial disparities in
colon cancer mortality. This would be achieved
when all groups have the same mortality rate, so
we will use a summary measure of health
disparity to determine if racial disparities in
working-age colorectal cancer mortality are
increasing or decreasing.
• Step 3: Choose a summary measure of health
disparity. Clearly, there is no natural ordering
among racial groups, so having decided to use a
summary measure of health disparity, we will use
the Between-Group Variance (BGV) to measure
the absolute level of disparity and two entropy-
based measures of relative disparity—the Theil
index (T) and the Mean Log Deviation (MLD).
Although it is not necessary to use both T and
MLD to measure relative health disparity, it may
be instructive to do so for reasons outlined below.
Results 
Table A2 (page 72) shows the colorectal cancer
mortality rate (µj), the rate relative to the
population average rate (i.e., the mortality ratio
rj), and the population share (pj) for each racial
group in 1990 and 2001. Recall that both T and
MLD are measures of average disproportionality—
that is, they take the general form and
measure the extent to which shares of population
and shares of health differ—but they use different
disproportionality functions (i.e., different speci-
fications of f(rj)). The disproportionality function
for T is rjln(rj) and for MLD is –ln(rj) or, equiva-
lently, ln(1/rj). It may not seem immediately clear
why it might be helpful to use both measures, but
it may be more clear if we use some simple
algebra to rewrite the equations. First, note that
when the denominator for the mortality ratio rj is
the total population rate, , where sj is the
share of mortality for racial group j. We can then
rewrite the disproportionality function f(rj) for T
as and MLD as . When we apply
the general formula for measures of
average disproportionality, the formula for T
becomes and MLD becomes .
Expressed in this fashion, it is clear that both T
and MLD measure the difference in (log) shares of
health (or ill health) and population, but T is
1n sj
pjpj ( (Σ1n pjsjsj ( (Σ
pj f (rj )Σ j
1n sj
pj( (1npjsj pjsj( (
rj x pj = sj
pj f (rj )Σ j
weighted by shares of health (or ill health, i.e., sj),
whereas MLD is weighted by population shares
(pj). Thus, in the context of our example T will be
somewhat more influenced by groups with high
mortality ratios, whereas MLD will be somewhat
more influenced by groups with large population
shares. 
Applying the disproportionality functions for
T and MLD listed in Table 2, in 1990 the
American Indian/Alaska Native segment of T is
calculated as 0.006 x 0.375 x ln(0.375) = 
–0.0023, and the segment of MLD is 0.006 x
[–ln(0.375)] = 0.062. The Between-Group Variance
(BGV) is calculated using equation [17] above and,
for the American Indian/Alaska Native segment in
1990, is calculated as 0.006  (9.5 – 25.5)2 = 1.607.
The racial disparity in 1990 as measured by the
Theil index is 0.0124. We might then immediately
ask whether this disparity is large or small.
Because there has been little use of entropy-based
measures in health disparities research, this is a
difficult question to answer. We may get some
leverage, perhaps, from the recent work by
Goesling and Firebaugh (101), who used T and
MLD to investigate trends in international health
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Figure A3. Trends in Mortality from Colorectal Cancer by Race, Ages 45–64, 1990–2001
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Figure A3.  Trends in Mortality from Colorectal cancer by Race, Ages 45-64, 1990-2001
* AI/AN = American Indian/Alaska Native
** API = Asian/Pacific Islander
Source: Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database, National Cancer Institute,
DCCPS, Surveillance Research Program, Cancer Statistics Branch, released December 2003.
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AI/AN* API** Black White 2010 Target
*AI/AN = American Indian/Alaska Native
**API = Asian/Pacific Islander
Source: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database, National Cancer Institute,
DCCPS, Surveillance Research Program, Cancer Statistics Branch, released December 2003.
disparity in life expectancy among 169 countries.
They report that in 2000 T for global disparity in
life expectancy was 0.0099 and MLD was 0.0106.
We find a T of 0.0198 and MLD of 0.0186 in
2002. Thus, it would appear that U.S. racial
disparities in colorectal cancer among those 45–64
are similar in magnitude to cross-national
disparities in life expectancy, but the extent to
which the number of groups compared (4 race
groups vs. 169 countries) and the health outcome
(colorectal cancer mortality rates vs. life
expectancy) may affect the level of disparity is an
open question. As additional analyses applying
entropy-based disparity measures within the
United States are conducted (102), a clearer sense
of how to interpret their magnitude should
develop. 
The results in Table A2 suggest that the
absolute racial disparity (BGV) in colorectal cancer
mortality rates remained approximately constant
over the period in question, but the relative
disparity increased and to a slightly greater extent
when measured with T than with MLD. The slight
difference between T and MLD results from the
fact that T is somewhat more affected by high
mortality ratios, and MLD is somewhat more
affected by large population shares (88). Thus, in
the case of colorectal cancer mortality, the Theil
will be more sensitive to mortality change in
blacks, and the MLD will be more sensitive to
mortality change in whites. The black mortality
ratio increased from 1.41 to 1.59 from 1990 to
2001, but the white ratio declined only slightly,
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Table A2. Example of Theil Index and the Between-Group Variance Applied to the Change in Racial
Disparity in Colorectal Cancer Mortality, 1990 and 2001
Rate per Population Rate Relative
100,000 Share to T otal T MLD BGV 
Race [µj] [pj ] [rj ] [pj x rj x ln( rj )] [pj x – ln( rj )] pj [( µj – ∑µj ) 2 ]
1990
American Indian/
Alaska Native 9.5 0.006 0.375 –0.0023 0.0062 1.607
Asian/Pacific Islander 14.5 0.026 0.570 –0.0084 0.0147 3.130
Black 35.9 0.100 1.412 0.0486 –0.0344 10.979
White 24.7 0.868 0.970 –0.0255 0.0263 0.502
T otal 25.5 0.0124 0.0128 16.219
2001
American Indian/
Alaska Native 10.4 0.009 0.541 –0.0029 0.0053 0.672
Asian/Pacific Islander 12.1 0.040 0.629 –0.0116 0.0184 2.018
Black 30.0 0.109 1.559 0.0751 –0.0482 12.561
White 18.3 0.843 0.950 –0.0410 0.0431 0.776
T otal 19.2 0.0198 0.0186 16.027
Note: Rates are age adjusted to the year 2000 population distribution and were generated by the National Cancer Institute’s SEER*Stat software, version 5.2.2.
from 0.97 to 0.95, thus favoring a relatively larger
increase in the Theil index.
Figure A4 shows the absolute and relative
disparity trends across the entire 11-year period,
which indicate that the change in racial disparity
was not constant over time. Both absolute and
relative disparity declined from 1990 to 1992,
after which absolute disparity rose to remain at
roughly its 1990 level for the rest of the period,
while relative disparity continued to increase
steadily as mortality rates declined for all racial
groups. On the whole, then, we would take a less
favorable view of the trend in racial disparities in
colorectal cancer compared to that of education-
related disparities in mammography. There
virtually was no decline in absolute disparity, and
relative disparity increased markedly from 1990 to
2002 despite an overall decline in the population
mortality rate.
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Figure A4. Racial Disparity Trends in Working Age (45–64) Mortality from Colorectal Cancer by Race,
1990–2001
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Figure A4.  Racial Disparity Trends in Working-Age (45-64) Mortality from Colorectal Cancer
                    by Race, 1990-2001
  * AI/AN = American Indian/Alaska Native
** API = Asian/Pacific Islander
Source: Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database, National Cancer Institute,
DCCPS, Surveillance Research Program, Cancer Statistics Branch, released December 2003.
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Source: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality—All COD, Total
U.S. for Expanded Races (1990–2001), National Ca cer Institute, DCCPS, Surveillance esearch Program, Cancer Statistics Branch,
released December 2003. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
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